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 Iron oxide nanoparticles are of great interest as contrast agents for research and 
potentially clinical molecular magnetic resonance imaging (MRI). Biochemically 
modifying the surface coatings of the particles with proteins and polysaccharides 
enhances their utility by improving cell receptor specificity, increasing uptake for cell 
labeling and adding therapeutic molecules. Together with the high contrast they produce 
in MR images, these characteristics promise an expanding role for magnetic nanoparticles 
and molecular MR imaging for studying, diagnosing and treating diseases at the 
molecular level. However, these contrast agents produce areas of signal loss with 
traditional MRI sequences that are not specific to the nanoparticles and cannot easily 
quantify the contrast agent concentration. With the expanding role of magnetic 
nanoparticles in molecular imaging, new methods are needed to produce a quantitative 
contrast that is specific to the magnetic nanoparticle. 
 
 This dissertation presents a new method for detecting and quantifying iron oxide 
nanoparticles using an adiabatic preparation pulse. It is shown through numerical 
simulation and experimental results that the adiabatic condition fails for spins diffusing 
near the particles, leading to a change in the image intensity that is proportional to the 
particle concentration. Importantly, the adiabatic contrast is linearly correlated with the 
total iron concentration, making it ideal for quantitative molecular imaging. Further, it is 
 xvi 
shown that the contrast is not very sensitive to inhomogeneities in the magnetic fields or 
magnetization transfer. This contrast was confirmed using 3 Tesla and 9.4 Tesla MR 
scanners, highlighting the translational potential of the approach for examinations and 
scientific research at clinical and ultra-high magnetic field strengths. 
 
 In the first aim, the theoretical foundation of the work is presented and a Monte 
Carlo simulation supporting the proposed mechanism of the contrast is described. 
Adiabatic pulse prepared imaging sequences are also developed for imaging at 3 Tesla 
and 9.4 Tesla, and the ability of the method to visualize and quantify the contrast is 
confirmed. Further, the physical characteristics of the nanoparticles and the preparation 
pulse and sequence parameters are modified to further characterize the approach. In the 
second aim, the contrast is characterized in more realistic phantoms, and a method to 
more accurately quantify nanoparticle concentration in the presence of magnetization 
transfer is presented. The sensitivity of the adiabatic contrast quantification to 
inhomogeneities in the magnetic fields and modifications to the pulse sequence 
parameters is also characterized. Finally, accelerated imaging methods are implemented 
to acquire the adiabatic contrast in a time compatible with in vivo imaging, and the 
technique is evaluated in several models of cellular and in vivo quantitative iron oxide 
nanoparticle imaging. Together, these aims present a method using an adiabatic 
preparation pulse to generate an MR contrast based on the microscopic magnetic field 
gradients surrounding the iron oxide nanoparticles that is suitable for in vivo quantitative, 








1.1 General Introduction 
 
 The use of Magnetic Resonance Imaging (MRI) for human disease diagnosis and 
monitoring has rapidly expanded over the past decades as a non-invasive, high resolution 
imaging modality. One of the greatest advantages of MRI is the ability to manipulate the 
pulse sequence to produce images sensitive to many different factors that can help 
physicians differentiate cancerous and non-cancerous lesions, for example. While MRI 
provides rich information from these changes in the tissue molecular environment, 
pertinent questions such as the number or presence of cancer signaling receptors on a cell 
surface cannot be asked with conventional imaging methods. Molecular MRI promises 
greater specificity and sensitivity than conventional MRI by producing images sensitive 
to specific molecules and using contrast agents to target specific cellular environments. 
These probes can either be endogenous contrast agents such as molecules or complexes 
made by the tissue of interest, or exogenous contrast agents that are administered to the 
subject to enhance a specific tissue. In either case, molecular contrast agents allow 
clinicians and researchers to visualize biomarkers of disease in vivo. The overall goal of 
this work is to diagnosis disease earlier with higher specificity, to monitor disease 
progression or treatment and to inform treatment decisions.  
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 Iron oxide nanoparticles are one type of exogenous contrast agent that can be 
administered to subjects in vivo to provide contrast in magnetic resonance (MR) images. 
These agents have been of intense research interest because they provide strong contrast 
in MR images, have surface coatings that can be modified for targeting to a specific 
biomolecular environment, and are largely biocompatible in vivo. While most of these 
studies are currently aimed at animal systems, there is hope that these approaches can 
eventually be translated into the clinical setting. In developing methods for molecular 
MR there are two parallel tracts: developing the contrast agents and developing the 
methods to detect the agents with MRI. As previous emphasized, an MR image is a 
function of dozens of parameters that affect the physics in the tissue and change the 
image intensity. The presence of a contrast agent in a tissue is not sufficient to provide 
useful information for the researcher or clinician; choosing the appropriate pulse 
sequence is essential for interpreting the image contrast. Together, these parallel lines of 
research are expanding the ability of MRI to characterize a subject at all levels from 
diffusion, to function, to molecule, to anatomy. 
 
 
1.2 Statement of Thesis 
 
 In this dissertation a new mechanism for detecting and quantifying iron oxide 
nanoparticles is presented. While this method adds to a number of methods for generating 
MR contrast from nanoparticles, generating contrast based on the microscopic 
environment of the particles has specific advantages that will be discussed. Additionally, 
the linear correlation of the contrast with iron oxide nanoparticle concentration is of 
particular note, as this straightforward relationship is of great importance for quantitative 
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molecular imaging. First, the theory underlying the method is presented along with 
numerical simulations and experimental results. Second, the technique is applied to more 
realistic phantoms and in vitro studies showing how the properties and parameters of the 
pulse sequence can be modified to increase the sensitivity and specificity of the 
quantification. Finally, in vivo studies are presented suggesting that the technique can be 
extended to animal, and eventually human, models of molecular MR. The 
accomplishment of these aims establishes and optimizes a new mechanism using 




1.2.1 Developing a Technique for Imaging Iron Oxide Nanoparticles with 
Adiabatic Pulse Preparation 
 
 As researchers develop an increasing number of iron oxide nanoparticle based 
contrast agents with increasing molecular and disease specificity, new mechanisms to 
detect and quantifying these contrast agents with complementary sensitivity and 
specificity are required. In this chapter, the theory of the adiabatic pulse prepared 
technique for imaging iron oxide nanoparticles is introduced. In order to characterize the 
mechanism, a Monte Carlo simulation is also developed suggesting that the failure of the 
adiabatic condition in the region surrounding the nanoparticle may be used as a contrast 
mechanism. The simulation results are confirmed by experiments on both clinical and 
research MR scanners, and the pulse parameters are modified suggesting approaches to 
 4 
modulate the sensitivity and specificity of the contrast. This work presents a new contrast 
approach that is linearly increasing with increasing nanoparticle concentration and is 
appropriate for quantitative molecular MR. 
 
 
1.2.2 Characterizing the Adiabatic Contrast in Phantoms and In Vitro 
 
 While numerical simulations and nanoparticles in solution present interesting 
results, in order to be applicable to in vivo models the quantitative characteristics of the 
method must be maintained in diverse molecular environments. In this chapter, the 
proposed method is extended to more realistic molecular environments, and a method to 
compensate for confounding magnetization transfer effects is developed. The robustness 
of the contrast is also characterized by investigating its sensitivity to changes in the 
molecular environment. Additionally, the sensitivity of the contrast to changes in the 
diffusion rate is characterized, and the ability of the method to quantify iron oxide 
nanoparticle labeled cells is demonstrated. Finally, the method is compared to other 
methods for detecting and quantifying nanoparticles, and its complementary role is 
emphasized. Here, the adiabatic pulse prepared method is shown to be insensitive to a 
number of factors that confound other methods of quantifying particles and applicable to 




1.2.3 Investigating Adiabatic Contrast In Vivo 
 
 In the final aim, the contrast mechanism is extended to be applicable to in vivo 
models of molecular imaging. First, the general applicability of the technique is greatly 
aided by implementing accelerated image acquisition schemes that dramatically reduce 
the total imaging time without sacrificing image contrast. Finally, a model of in vivo 
animal imaging following iron oxide nanoparticle accumulation in the mouse liver is used 
to validate the linear correlation of image contrast with liver iron concentration measured 
ex vivo. The results show that the adiabatic pulse prepared contrast technique is suitable 






1.3.1 Magnetic Resonance Imaging 
 
 Today MRI is a rapidly growing tool aiding clinical diagnosis around the world, 
but its basis if firmly planted in the discoveries of spectral line splitting by Zeeman (1) 
and nuclear magnetic resonance (2, 3) many decades ago. However, it was not until 
Lauterbur (4) and Mansfield and Grannell (5) that these discoveries were combined with 
methods to spatially localize the NMR signal that MR images were formed. Today, the 
numerous diseases and applications studied by MRI are a testament to the flexibility of 
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the underlying physics to provide diagnostic information safely and non-invasively. In 
this brief introduction, the origin of the MR signal will be defined as well as the effect of 
applied radiofrequency (RF) pulses and contrast agents. The following work applies these 
concepts to a specific application of adiabatic preparation pulses and iron oxide 
nanoparticles. 
 
 Hydrogen nuclei are ubiquitous throughout the body as the building blocks of 
water. These nuclei are very important for MRI because they possess the fundamental 
property of nuclear spin 1/2 due to their unpaired proton and no neutrons. This means that 
when placed in an external magnetic field, B0, the spin precess about the external field at 
a frequency proportional to the static field, B0, and the gyromagnetic ratio, , of the nuclei 
(all equations in this chapter from (6)): 
 
         (1.1)  
 
However, we cannot detect the magnetization vector until it is rotated into the plane 
perpendicular to the external magnetic field where it can be detected by receiver coils. 




    
  
         (1.2) 
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By adding a second magnetic field perpendicular to the B0 field, the spin can be rotated 
from its current position. Here we can simplify the mathematics by introducing a primed 
coordinate systems that rotates with the external magnetic field. It can further be derived 








             (1.3) 
 
By defining the frequencies of the spins based on equation 1.1 and the static magnetic 
field, , the rotating magnetic field, , and the frequency of the applied magnetic field, 
, the effective magnetic field for the MRI experiment can be defined: 
 
        
             




For most MR experiments the applied field is selected to be equal to the Larmour 
Frequency of the precessing spins, = 0. However this does not necessarily have to be 
the case, as will be shown for the adiabatic passage that is the primary interest in this 
dissertation. 
 
 Once an RF pulse rotates a spin system into the transverse plane the spins begin to 
precess about the static magnetic field, producing a magnetic flux through the receiver 
coil which in turn induces a current and a signal measurement. If each spin started with 
the same initial phase in a homogeneous magnetic field we would expect their phases 
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relative to one another to remain constant, since each spin would be precessing at exactly 
the same frequency. However, the magnetic field is never exactly homogenous. The 
accumulated phase at position r can be defined as: 
 
                      (1.5) 
 
Thus, the addition of a magnetic field component that varies in space and time produces 
different phase accumulations over the region of interest. The greater the variation in the 
magnetic field or the longer the time that the phases accumulate, the greater the phase 
difference between two subsets of spins.  
 
 Additionally, after the magnetization vector has been rotated from the 
longitudinal direction into the transverse plane it will relax back towards its original state. 
If we simply consider the case where the entire longitudinal magnetization was tipped 
into the transverse plane, the recovery of the longitudinal magnetization can be given as: 
 
             
  
  
   (1.6)
 
For this case, the recovery of the system is described by the time constant T1, or the 
“spin-lattice” relaxation time. A second parameter related to the dephasing of the spins is 
the transverse relaxation time constant T2, or the “spin-spin” relaxation. Here again, if the 
magnetization is tipped into the transverse plane at time, t = 0, and if the signal is 
refocused at an echo time TE: 
 9 
 
              









Differential tissue relaxation rates, along with variations in spin densities, cause different 
tissues to have different intensities within a single MR image. In fact, it was recognized 
early in development of MRI that cancerous tissue may be distinguished from healthy 
tissue (7). Therefore, informed by the different properties of the tissue, pulse sequences 
can be designed to accentuate or quantify changes in the relaxation rates (8). While these 
tissue differences act as endogenous contrast, MR imaging is not limited to native tissue 
contrast. Exogenous contrast agents can be designed with these same physical principles 
in mind to aid in tissue characterization (9). 
 
 
1.3.2 Contrast Agents for Molecular Magnetic Resonance Imaging 
 
 While MRI provides exquisite soft tissue contrast, simply due to changes in spin 
density and relaxation rates, contrast agents can add information based on the underlying 
cellular biology and physiology to which MR is not otherwise sensitive (10-12). These 
contrast agents can either be exogenously administered to the subject where they 
differentially accumulate to highlight a tissue of interest (13, 14), or they can be 
endogenously produced by the tissue either where their role as a contrast agent is 
secondary to their biological role, or as a reporter gene where their expression is 
controlled at the genetic level (15-17). Perhaps the most broadly applied endogenous 
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contrast is deoxyhemoglobin, where its correlation with neural activation is the basis for 
functional magnetic resonance imaging (fMRI) (18) and the dynamic mapping of brain 
activity (19). However, for molecular imaging most contrast agents are developed in the 
laboratory. 
 
 The overall goal of a molecular MR contrast agent is to affect the MR signal in an 
area based on low concentrations of a molecular target or small changes in the 
biochemical environment (20). While ultrasound agents affect sound reflection (21) and 
computed tomography uses changes in density (22), MR contrast agents often change the 
relaxation rates of the surrounding molecules (23). As previously described, changes in 
the longitudinal relaxation rate (1 / T1) and transverse relaxation rate (1 / T2) affect the 
measured MR signal. T1 agents that increase the relaxation rate generally lead to an 
increase in signal on T1 weighted images, while T2 agents that increase the transverse 
relaxation rate lead to a decrease in signal in T2-weighted images. Two of the most 
studied MR contrast agents are gadolinium and magnetic nanoparticles. 
 
 Gadolinium is a rare earth metal that is the most widely used paramagnetic 
contrast agent in the clinical setting since its application to cerebral brain tumors (24). 
Today, clinical applications of gadolinium include cardiac (25), vessel (26) and hepatic 
imaging (27). While gadolinium-based contrast agents have previously been associated 
with the development of nephrogenic systemic fibrosis in patients (28), more recent 
studies have shown a dramatic decrease in the complication rate by changing the type and 
method of contrast administration (29). An additional concern for molecular imaging is 
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the potential for gadolinium to effect cellular processes (30). However, gadolinium is still 
an essential part of many clinical exams, and since it is primarily a T1 contrast agent, it 
produces increased signal intensity in T1-weighted MR images. When used as a positive 
contrast agent it can be detected in the micromolar concentrations applicable to molecular 
imaging (31) 
 
 While the T1 agents maintain inherent imaging advantages, T2 agents such as iron 
oxide nanoparticles may have greater potential for molecular imaging. One natural 
advantage of iron-based contrast agents is that iron is a ubiquitous element in the body 
that plays an important chemical role in many oxidation-reduction reactions, and 
therefore cells have pathways for degrading iron into the hemoglobin pool (32). 
Biocompatibility studies in animals (33) and clinical experiences in humans (34) have 
lead to the clinical approval of an iron oxide as a contrast agent for hepatic imaging (35). 
Even without surface modifications to target the particles to specific cell receptors, 
circulating iron oxide nanoparticles provide useful information on the tissue molecular 
environment. This passive targeting results in image contrast based on nanoparticle 
uptake by immune cells present in healthy liver tissue but absent in cancerous tissue (36), 
accumulation of particles in normal lymph nodes (37, 38), and escape of nanoparticles 
from leaky tumor tissue vasculature (39).  
 
While there is a broad range of molecular contrast agents, exogenous iron oxide 
nanoparticles are the most widely studied (40). Since these superparamagnetic iron oxide 
(SPIO) contrast agents have a significantly greater effect on the transverse relaxation rate 
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compared to the longitudinal relaxation rate, these agents produce a negative contrast that 
is difficult to localize and quantify. While SPIO nanoparticles have a measurable effect 
on the longitudinal relaxation rate, especially with ultrashort echo time imaging (41), 
changes in T2* and T2 have been more widely applied (42). The effect of these contrast 
agents on the images is related to the size, composition and concentration of the 
nanoparticles. 
 
 The iron oxide core and surrounding coating combine to determine the tissue 
specificity and effect on the MR signal (43). Most nanoparticles have cores composed of 
magnetite (Fe3O4) and/or maghemite (Fe2O3) that have saturation moments of 127 
emu/g Fe and 78 emu/g Fe respectively (44). While numerous methods have been 
developed to manufacture these iron oxide nanoparticles (14), coprecipitation of Fe(II) 
and Fe(III) under specific conditions is the most common (45). While the particles can be 
manufactured over a range of a few nanometers (46) to several microns (47), for in vivo 
applications the size range is limited by its interaction with the body. Generally, particles 
smaller than 7-10 nm are filtered through the kidney glomerulus where they are excreted 
in the urine (48, 49), while particles larger than 100 nm have an increased likelihood of 
being removed from circulation in the liver and spleen by the reticuloendothelial system 
(50). 
 
 In addition to the physiological advantages of this mid-size range, particles with 
diameters of 2 to 20 nm can be superparamagnetic. This means that while their 
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magnetization flips randomly in the absence of an external magnetic field (44), when an 
external magnetic field is applied, the magnetic moment quickly aligns with the direction 
of the applied magnetic field, and the saturation magnetization is achieved (51). These 
properties make the particles extremely useful in the MR experiment where the static 
magnetic field induces these changes and produces dramatic contrast given their small 
size. 
 
 An equally important part of the nanoparticle is the coating of the iron oxide core. 
The surface coating allows for particle stability in the aqueous environment of the body 
as well as providing a platform for surface modifications, including proteins and 
polysaccharides that can be added to target the particles to a specific molecular 
environment (52, 53). The primary particle coating is dextran (54), a polysaccharide of 
glucose, that increases the circulation time of the particles (55) while decreasing the 
chance of undesirable uptake by the immune system (56). Additionally, the coating can 
be modified to affect the relaxivity of the particle (57, 58). Combined, these changes 
make the surface coating of the particle a key modulator of the spatial localization of the 
particles and their affect on the MR signal. 
 
 Iron oxide nanoparticles produce contrast in MR images by creating 
inhomogeneities in the magnetic field. The magnetic nanoparticle changes the 
surrounding magnetic field where the spins contributing to the MR signal are located. For 
a spherical iron oxide nanoparticle, the change in the external magnetic field can be 
described by (59): 
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           (1.8) 
 
Where  is the change in susceptibility, B0 the external magnetic field, a the particle 
radius,  the angle in spherical coordinates, and r the distance from the particle center. 
From this equation, it can be seen that the local magnetic field changes based on the 
physical properties of the nanoparticle (magnetic susceptibility and particle size) and 
spatial location (distance and orientation to the particle). Figure 1.1 shows that when 











 With the colorbar on the right of Figure 1.1 showing the range of frequency 
change in the region surrounding the particle, the origin of the T2-weighted contrast 
becomes apparent. As different spins precess at different frequencies they accumulated 
phase differences that lead to a decrease in phase coherence and a decrease in signal with 
increasing time. As the magnitude of the inhomogeneities or the number of nanoparticles 
increases, the signal intensity on T2-weighted imaging decreases. However, this does not 
mean that there must be a decrease in image intensity for every MR sequence when iron 
oxide nanoparticles are present. As will be shown, by knowing the effects of the magnetic 
nanoparticles on their surroundings, schemes can be developed to enhance signal from 
the region surrounding the nanoparticle compared to the background. 
 
 
1.3.3 Adiabatic Pulses 
 
 Adiabatic pulses are amplitude and phase modulated RF pulses that can be 
implemented on clinical and research MR scanners (60). Pulses modulated in phase (or 
frequency) were common in early NMR experiments where excitation was accomplished 
by sweeping the effective magnetic field in the presence of continuous wave RF 
irradiation (61). However, MR systems today are engineered to provide a uniform, static 
main magnetic field. In practice, the adiabatic passage is accomplished by modulating the 
amplitude and phase of an RF pulse in the presence of a constant main magnetic field. 
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 One practical advantage of adiabatic pulses is that they are very insensitive to the 
homogeneity of the B1 field, and these pulses are often used to produce uniform 
excitation and inversion pulses (62, 63). However, this uniformity comes at the expense 
of limiting the applications of adiabatic pulses compared to conventional RF pulses. For 
example, the rotation of the magnetization does not have the same relationship between 
power and time as a conventional pulse. In the case of a pulse applied at the Larmor 
frequency along an axis in the transverse plane, the resulting flip angle is defined by: 
 
              (1.9) 
 
Where  is the duration and B1 is the magnitude of the applied magnetic field. By this 
equation the duration and power of the pulse can be changed to produce not only an 
excitation, inversion, or refocusing pulse, but any intermediate flip angle can be achieved 
with the appropriate local parameters. 
 
 An adiabatic full passage pulse rotates the effective applied magnetic field and the 
magnetization 180 degrees provided the adiabatic condition is fulfilled (64). In order to 
explain how this occurs, a coordinate system is defined that rotates with the applied 
magnetic field (65). In Figure 1.2 the main magnetic field is aligned with the zʹ direction, 
and before the pulse is applied the magnetization precesses about the zʹ axis. For a 
conventional RF pulse applied at the Larmor frequency, the B1 field would be applied in 
the transverse plane, and the magnetization would rotate about that direction. However, if 
a pulse begins off resonance, in the rotating frame this corresponds to a component along 
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the zʹ direction – parallel with the magnetization vector. The magnitude of this vector is 
proportional to the distance off-resonance, so as the frequency approaches the on-
resonance condition this magnitude diminishes. The second component is the magnitude 










 When the adiabatic pulse begins far from resonance with a small magnitude 
relative to the off resonance, the magnetization and the effective applied field begin 
parallel, and the magnetization precesses about the applied magnetic field. Figure 1.2 
shows that by modulating the frequency and amplitude of the adiabatic pulse, the 
magnetization follows the applied field as it rotates from its initial orientation. Many 
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methods for performing the adiabatic passage have been developed and optimized (66-
70), but one of the most common adiabatic pulses is the hyperbolic secant pulse defined 
by the following amplitude and frequency modulation (64): 
 
         
           (1.10) 
 
                    (1.11) 
 
Here,  and  define the bandwidth of the pulse frequency sweep. Figures 1.3 and 1.4 
show the amplitude and phase modulation of a hyperbolic secant pulse. The bandwidth, 
as included in the phase modulation, can be optimized for the desired application. As will 
be formally described, both the magnitude and range of frequency sweep affect the 















 However, the adiabatic passage only occurs if the pulse rotates slow enough so 
that the effective magnetic field changes more slowly than the rotation of the 
magnetization about the effective field (71). This limitation is a function of the 
acceleration of the field rotation, which can be described by: 
 
             
      
     
  (1.12) 
 
This equation gives rise to the “adiabatic condition” that must be satisfied for the pulse to 
perform as desired: 
 
                   (1.13) 
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From this equation we can see that the adiabatic condition may be fulfilled by either 
increasing the amplitude of B1 or by decreasing the acceleration of the frequency sweep. 
The former condition highlights the characteristic of the pulse that once the adiabatic 
condition is fulfilled, further increases in power will not change the flip angle. As such, 
these pulses are often used in cases where the B1 field may be very inhomogeneous, such 
as in transceiver surface coils (72). 
 
 Simulation with the Bloch equation highlights the uniformity and frequency 
selection of the adiabatic full passage. Figure 1.5 shows that for a pulse with a - / + 5 kHz 
frequency sweep, near uniform inversion is achieved for spins within this frequency 
range. For spins outside this range the magnetization remains as it was before the 
application of the pulse. Additionally, the transition between the two states is narrow and 










 Figure 1.6 shows the transverse component of the signal, which again 
demonstrates the ideal behavior of the pulse within the frequency range of the pulse. As 
will be shown in the following studies, the transition between the range within and 
outside the frequency sweep produces a variable transverse and longitudinal component. 
However, the ideal inversion profile for the spins that achieve the adiabatic full passage 









 Though their uniformity provides many advantages, one drawback of these pulse 
is that they are most directly used to produce full (180 degree) and half (90 degree) 
rotations; however, multiple passages with phase offsets can be used to produce other flip 
angles (73, 74). While the adiabatic pulse principles have been applied to many MR 
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techniques including spectroscopy localization (75) and slice selection (76), and 
continuous labeling of flowing spins (77, 78), the adiabatic passage and the failure of the 






DEVELOPING A TECHNIQUE FOR IMAGING IRON OXIDE 




 Iron oxide nanoparticles have tremendous potential as magnetic resonance 
imaging (MRI) contrast agents to aid disease detection and treatment monitoring in the 
research and eventually clinical settings. This chapter introduces a new method for 
generating contrast from iron oxide nanoparticles using an adiabatic preparation pulse. 
First, the mechanism is validated with a Monte Carlo simulation, and then the pulse 
sequence is implemented on clinical and research MR scanners with magnetic field 
strengths of 3 Tesla and 9.4 Tesla. Images are created to visualize the positive contrast, 
and the contrast is quantified over a range of iron concentration used in molecular MR 
imaging. Next, iron oxide nanoparticles with specific core diameters are manufactured to 
characterize the effect of the physical parameters of the nanoparticles on the adiabatic 
contrast. Finally, the parameters of the pulse sequence are modulated to characterize the 
contrast and increase the sensitivity of the technique based on the proposed mechanism. 
This work represents the first report of the adiabatic pulse prepared contrast mechanism 






 As the number of research applications of iron oxide nanoparticles grows and 
there is increasing hope that these discoveries will lead to clinical diagnostic tools, 
sensitive and specific methods for imaging iron oxide nanoparticles will become 
essential. While a number of methods for producing increased signal from the regions 
surrounding the particles have emerged, most of these methods rely on changes in the 
macroscopic magnetic field surrounding the particles. While increased signal alone may 
hold some advantages for contrast localization, such approaches do not inherently 
overcome all the challenges to detecting and quantifying the nanoparticles. With this in 
mind, our goal was to develop a technique for the quantitative imaging of iron oxide 
nanoparticles that is sensitive to the microscopic magnetic field surrounding the particles. 
We will show that an adiabatic preparation pulse can be used to produce a signal that is 
both linearly increasing with increasing iron concentration and sensitive to the local 
microscopic magnetic field. 
 
 While many methods have been able to successfully detect the nanoparticles 
using MRI, challenges to increasing sensitivity and optimizing quantification remain. 
One method for increasing the signal from regions containing iron oxide nanoparticles is 
an approach using unbalanced gradients called the white marker method. In this 
approach, unbalanced gradients are used to selectively refocus the signal surrounding a 
region of SPIO nanoparticles using a mechanism similar to that which recovers MR 
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signal in regions with susceptibility changes in a T2* weighted image (79). Specifically, 
unlike in a standard imaging sequence where the slice select gradient is completely 
refocused to maximize signal from excited spins, the white marker method incompletely 
refocuses the slice selection gradient. As a result, the signal from regions having a 
homogenous field is suppressed by incomplete refocusing, while the bulk magnetization 
in some regions inside the SPIO’s negative dipolar field achieves a more complete 
refocusing, producing a brighter signal. While improvements to this technique have been 
made using positive and negative gradients to decrease the sensitivity to partial volume 
effects, the region of increased signal intensity extends beyond the localized contrast 
agent making extension to molecular imaging applications more challenging (80). 
 
 Another approach to producing signal from the off-resonance components is to 
use spectrally selective RF pulses to selectively image the off-resonance spins. In one 
method a -800 Hz off resonance pulse is used to excite and refocus the spins surrounding 
iron oxide labeled cell (81). This method is able to manipulate the larger macroscopic 
magnetic field to produce a dumbbell shaped signal intensity corresponding to a 
collection of SPIO labeled cells, while the off resonance pulse has little effect on the 
tissue that does not contain nanoparticles. Also, the slice selectivity of this approach has 
been updated to address the issues of off-resonance signal from adjacent slices by using 
self-refocused, spatial-spectral pulses to enhance slice selectivity (82). 
 
 Susceptibility mapping is also of growing interest, as a direct measurement of 
susceptibility may allow for the quantification of elements such as iron and calcium in 
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addition to exogenous contrast agents (83). Techniques for susceptibility mapping 
including susceptibility gradient mapping (84) and phase gradient mapping (85) rely on 
post processing to identify inhomogeneities in the local magnetic field. However, these 
techniques may be sensitive to the model parameters selected (86) and may not be ideal 
for quantifying continuous distributions of iron oxide such as in targeted models of 
cancer imaging (87). 
 
 Another method, Inversion-Recovery with ON-Resonant Water Suppression 
(IRON), uses a spectrally selective RF pulse to saturate the on-resonance magnetization 
and then image the off-resonance component (88). This method uses a pair of 180 degree 
pulses with delays for fat-suppression to null the short-T1 component. The sequence then 
applies a saturating preparation pulse with a 100 Hz bandwidth, a 50 msec duration and 
an excitation angle of 100 degrees (89). The narrow frequency of the preparation pulse is 
less effective at saturating the broadened frequency spectrum produced by the presence of 
the SPIOs as compared to the case of the narrower frequency spectrum in the absence of 
SPIOs. Following the saturation pulse, a broad-band pulse is used in the imaging 
sequence to capture the spins that were not saturated by the narrow, on-resonance 
preparation pulse, and an image is produced with increased signal from the tissue where 
SPIOs produce a broader frequency spectrum. 
 
 While these methods for imaging the off-resonance magnetization produce a 
positive contrast from the nanoparticles, they rely on the manipulation of the bulk 
magnetization. Because these mechanisms produce increased signal based on changes in 
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the macroscopic magnetic field, the quantification of the nanoparticle concentration is 
based on an area or volume of increased signal in the image (90). Thus, the measure is 
inherently not spatially specific and does not directly probe the microscopic biological 
environment. Additional technical challenges include incomplete background suppression 
due to inhomogeneity in the B1 field and fat suppression from inhomogeneities in the B0 
field (88). 
 
 Next, the off-resonance saturation (ORS) technique uses the microscopic 
magnetic field inhomogeneities produced by the SPIO nanoparticles to selectively 
saturate a volume of spins surrounding the nanoparticle (91). In this technique a 
saturation pulse is applied at a frequency that is offset from water but found in a shell of 
the dipolar field surrounding the nanoparticle. The method’s ability to detect targeted 
contrast agents in an in vivo cancer model demonstrates its low concentration detection 
limit (92). However, challenges for the technique include sensitivity to the B0 field 
homogeneity as changes in the local frequency profile effect the quantification, and the 
correlation of the contrast with the nanoparticle concentration may not be linear over the 
range of nanoparticle concentrations used in molecular MR imaging. Finally, several 
methods of steady state imaging to enhance signal from iron oxide nanoparticles have 
also been described (93, 94). 
 
 While all of these techniques successfully produce signal from the iron oxide 
nanoparticles, accurate spatial localization and especially nanoparticle quantification 
remain active research areas. With the adiabatic preparation pulse method, we hope to 
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add a mechanism for detecting and quantifying iron oxide nanoparticles in phantoms, in 





 As was previously described, an iron oxide nanoparticle in a static magnetic field 
produces a surrounding dipolar magnetic field that introduces inhomogeneities into the 
otherwise homogeneous magnetic field. While these inhomogeneities increase the 
transverse relaxation rate, R2, as spins diffusing through different local magnetic fields 
loose phase coherence, it has also been shown that spins can be saturated as they diffuse 
through these microscopic magnetic fields to produce a contrast sensitive to these local 
changes (91). Since each spin starts at a different location and experiences a different 
time-varying magnetic field during its random walk diffusing throughout the spatially-
varying molecular environment, a contrast sensitive to the diffusion of spins near the 
particles should be able to detect and quantify the number of nanoparticles. It is 
hypothesized that an adiabatic preparation pulse can be used to sensitize an image to the 
presence and concentration of iron oxide nanoparticles. 
 
 For pure water with a single resonance frequency, an adiabatic full passage 
preparation pulse inverts the magnetization according the previously described theory.  
Provided the pulse applies adequate power and the frequency modulation is sufficiently 
slow, the magnetization follows the effective magnetic field during its rotation. In this 
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case, the strength of the effective magnetic field remains much greater than the angular 
velocity of the applied magnetic field during the entire passage, and thus the adiabatic 
condition is fulfilled. However, for spins precessing at a frequency that is offset relative 
to the applied field, the ability of the pulse to rotate these spins is a function of their 
offset relative to the applied pulse and the frequency sweep (BW) of the adiabatic 
passage. It can be shown through sweep diagrams that spins within the frequency sweep 
will be inverted, and those outside the frequency sweep will be returned to their original 
orientation (95). 
 
 However, the presence of iron oxide nanoparticles does not simply create two 
spin populations: one within the frequency sweep and one outside. Rather, the presence 
of the magnetic dipoles creates an inhomogeneous molecular environment where spins 
experience temporally and spatially varying magnetic fields during their continuous 
diffusion. It is hypothesized that the failure of the adiabatic condition for spins diffusing 
near the nanoparticles can create a contrast that will allow for the detection and 
quantification of the particles. The basic concept of this method is presented in Figure 
2.1, where the adiabatic passage performs as expected for spins that do not diffuse near 











 As spins diffuse through the rapidly changing magnetic field gradients near the 
particles, there is a corresponding variation in the effective B1 that also contributes to the 
failure of the adiabatic condition. Once the adiabatic condition fails, the spin is no longer 
locked to the applied field, and the flip angle is defined by the more conventional 
function of time and B1 pulse power: 
 
           (2.1) 
 
 As a function of time and power, the flip angle for a spin that fails the adiabatic 
condition is dependent on when the adiabatic passage was abandoned. However, since 
complete inversion maximizes the magnitude of the Mz magnetization, any other flip 
angle produces a decrease in the relative Mz magnetization magnitude compared to the 
complete adiabatic passage. By comparing images acquired with and without the 
adiabatic preparation pulse, the number of spins failing the adiabatic condition can be 
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quantified. This measure should be proportional to the concentration of nanoparticles, as 
the number and volume of local magnetic field gradients producing the contrast is 
proportional to the number of particles. 
 
 Therefore, it is proposed that the rapidly changing local magnetic field gradients 
near the iron oxide nanoparticles will lead to the failure of the adiabatic condition for 
spins diffusing near the particles. This failure should be proportional to the number of 
particles, since there is a direct relationship between the volume of these dipoles and the 
number of nanoparticles. This approach represents a new method for detecting and 
quantifying iron oxide nanoparticles based on the failure of the adiabatic condition on the 
nanometer scale near the particle. Also, since it is not sensitive to a single off resonance 






 The primary objectives of this chapter are to (a) support the proposed contrast 
mechanism with numerical simulation, (b) demonstrate the visualization and 
quantification of the adiabatic contrast at clinical and research magnetic field strengths, 
and (c) characterize the contrast produced by changing both the physical properties of the 
nanoparticles and the parameters of the pulse sequence. While the challenges confronted 
when imaging nanoparticles in diverse molecular environments, such as in vivo, will be 
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addressed in subsequent chapters, this work focuses on detecting and quantifying 
nanoparticles in solution. 
 
 
2.3.1 Monte Carlo Simulation of the Adiabatic Contrast 
 
 A Monte Carlo simulation was developed in MATLAB in which spins diffused 
through a nanoparticle containing environment during the application of an adiabatic RF 
pulse. Iron concentrations consistent with those used in molecular imaging experiments 
were first defined, and then the distribution of the nanoparticles in the environment was 
derived from the assumption of 6070 iron atoms per nanoparticle (96). For the 
simulation, each spin was randomly assigned an initial spatial position within an 
environment of equally spaced particles. Then the spins were allowed to diffuse in three 
dimensions, with the diffusion distance in one dimension, , during a given time-step, : 
 
          (2.2) 
 




 / sec. Assuming 
a 10 millisecond adiabatic preparation pulse the spins will diffuse an average of 12.2 
micrometers in three dimensions. For the simulation, the time step was decreased to 1 
nanosecond, which gives an average diffusion distance of 3.9 nm in each dimension. 
Since increasing the spatial resolution increases the computational power required for the 
simulation, as well as contributing to the rounding error in the calculation, this resolution 
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relative to a 6 nm diameter nanoparticle with a one radius length exclusion zone was 
determined to be sufficient for preliminary studies. 
 
 During the diffusion of the spin, a 10 msec hyperbolic secant adiabatic full 
passage pulse with a -/+ 1000 Hz frequency sweep was applied, and the magnetization 
was calculated using the Bloch equation. For each time-step the local magnetic field was 
calculated based on the magnetic field produced by the nearest nanoparticle as well as the 
contributions to the total magnetic field from the neighboring particles. The maximum B1 
power was chosen to be 0.55459 G for the simulations, the B1 used in the following 
phantom experiments at 3 Tesla. The longitudinal magnetization at the conclusion of the 
pulse was averaged for 500 spins at each iron concentration. 
 
 
2.3.2 Preparing Sample Nanoparticles  
 
 Dilutions of iron oxide nanoparticles in water were prepared at iron 
concentrations appropriate for molecular imaging. For the initial visualization and 
quantification experiments Feridex (Advanced Magnetics, Inc., Cambridge, MA) was 
prepared with a total iron concentration ranging from 0 to 1 mM in a total volume of 1.5 
mL. The samples were contained in 2.0 mM polypropylene, round bottom cryogenic vials 
(Corning Inc., Corning, NY). Due to the discontinuation Feridex manufacture, and the 
desire to characterize the contrast generated by particles of a narrower diameter, 
nanoparticles with iron oxide cores of 6.9, 11.0 and 15.0 nm were prepared in the 
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laboratory of Dr. Gang Bao. Since these particles had greater effects on relaxivity, a 
lower iron concentration range was chosen between 0 to 0.3 mM which produced 
transverse relaxation rates comparable to those of the Feridex phantoms. 
 
 
2.3.3 Imaging at 3 Tesla 
 
 An adiabatic pulse prepared spin-echo imaging sequence was implemented within 
the Siemens IDEA programming environment. The adiabatic preparation pulse was 
computed in MATLAB based on the duration and frequency sweep desired. For the 
initial experiments, a 10 millisecond hyperbolic secant pulse with a -/+ 1000 Hz 
frequency sweep was used. For each subsequent combination of pulse duration and 
frequency sweep, a new pulse waveform was calculated in MATLAB and the pulse 
duration was entered on the MR scanner at runtime. All studies where performed on a 3 
Tesla Siemens Magnetom Trio (Siemens Medical Solutions, Malvern, PA) using a 
transmit/receive wrist coil.  
 
 The pulse power required for adiabatic passage and the adiabaticity were 
determined and confirmed experimentally. Water phantoms were used, and the maximum 
peak power of the adiabatic full passage pulse was increased stepwise. With increasing 
power, the signal eventually plateaued at a maximum intensity and remained constant as 
the power was increased beyond this level. This nonconventional relationship of pulse 
power with flip angle is theoretically expected and confirms that the full passage 
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inversion was successful. To ensure that the adiabatic condition was fulfilled, the power 
chosen for the quantification experiments was approximately 20% greater than the power 
at which the adiabatic condition was fulfilled in the water phantom. Imaging parameters 
for the phantom experiments at 3 Tesla included: TE: 15 ms, TR: 10s, matrix: 128x128, 
acquisition time: 21 min, slice = 2 mm, FOV= 70x70 mm.  
 
 An adiabatic zero passage preparation pulse was also developed to increase 
imaging sensitivity. Here, two adiabatic full passage pulses are played back-to-back to 
return the magnetization to the original orientation. While the frequency sweep of the 
pulse is identical to the full passage pulse, the duration of the zero passage is twice as 
long. The increased diffusion time should theoretically increase the likelihood of the 
adiabatic condition failing, and this approach may increase the sensitivity for detecting 
very low concentrations of iron oxide nanoparticles. 
 
 The adiabatic contrast was quantified by the normalized difference of images 
acquired with and without the adiabatic preparation pulse. As the adiabatic condition fails 
for more spins in samples with higher nanoparticle concentrations, a decreased number of 
the spins are fully inverted, and thus the image intensity is decreased. By subtracting the 
adiabatic pulse prepared image from the image without the preparation pulse and 





2.3.4 Imaging at 9.4 Tesla 
 
 In order to extend the proposed technique to magnetic field strengths increasingly 
used in molecular imaging studies, especially with small animals, an adiabatic pulse 
prepared sequence was similarly implemented on an ultra-high magnetic field MRI. All 
studies were conducted on a 9.4 Tesla Bruker Bio-Spec 94/20 (Bruker BioSpin 
Corporation, Billerica, MA) using a 3 cm transmit/receive volume coil. The Bruker 
optimized 10 millisecond hyperbolic secant pulse with a 1760 Hz bandwidth was used, 
and a 20 ms zero passage pulse was similarly constructed by applying two full passage 
pulses back-to-back. The adiabaticity and pulse power for the preparation pulse was 
determined experimentally with a water phantom. Imaging parameters for phantom 
studies at 9.4 Tesla for included: TE: 10.25 ms, TR: 10 s, matrix: 128x128, acquisition 





2.4.1 Monte Carlo Simulation of Adiabatic Contrast 
 
 Numerical simulation confirmed that the adiabatic condition fails for spins 
diffusing near iron oxide nanoparticles. Figure 2.2 shows that for the lowest iron 
concentration, where the particles are spaced furthest apart, the average Mz magnetization 
at the conclusion of the preparation pulse is near -1, indicating a complete inversion. As 
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the iron concentration increases and the particles and their magnetic field gradients move 
closer together, the average magnetization decreases. In fact, it is exciting to note that the 










 By plotting a histogram of the Mz magnetization at the conclusion of the 
preparation pulse, the failure of the adiabatic condition for the individual spins is more 
apparent. In Figure 2.3 at the lowest iron concentration nearly all the spins are inverted as 
expected, but as the nanoparticle concentration increases the number of spins that are not 
completely inverted increases as well. When examining higher iron oxide concentrations 
such as in Fig. 2.5, the expected behavior of the adiabatic full passage is absent. Since the 
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behaves as a conventional RF pulse rather than an adiabatic pulse. As the failure of the 
adiabatic condition is not simultaneous, the final flip angle is random without a 





















































2.4.2 Visualizing and Quantifying the Adiabatic Full Passage Contrast at 3 Tesla 
 
 T2-weighted, spin-echo images showed decreased signal intensity with increasing 
iron concentration as expected. When the adiabatic full passage preparation pulse was 
applied there was an even greater decrease in image intensity at higher iron 
concentrations, but importantly, there was still sufficient signal from the highest iron 
concentrations to perform contrast quantification. While these images still show a 
decrease in signal, when the normalized difference between images with and without 
adiabatic preparation were computed to visualize the failure of the adiabatic condition, 
















Mz at end of adiabatic full passage 
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the T2-weighted image intensity (center) has an inverse relationship with the adiabatic 






Figure 2.6: Iron-oxide nanoparticles (mM) in solution (left), T2-weighted spin echo (center) and AFP 




 Quantifying the signal intensity in the adiabatic contrast image showed a highly 
linear correlation of iron concentration with adiabatic contrast over the range of iron 
concentrations studied (R
2
 = 0.9951). In order to quantify the sensitivity of the method, 
the minimum detectable concentration, defined as the concentration with five times the 
contrast to noise ratio, was measured with extremely low nanoparticle concentration 
phantoms. For the adiabatic full passage experiment, the minimum detectable 
concentration was determined to be 0.05 mM. For iron concentrations beyond this range, 













2.4.3 Visualizing and Quantifying Adiabatic Full Passage Contrast at 9.4 Tesla 
 
In order to facilitate the application of the proposed method to biological research 
models, the method was implemented on a 9.4 Tesla small-bore animal scanner. While 
magnets of this strength are not yet available for regular clinical applications, the 
increased signal and higher gradient strengths make them desirable for the in vivo study 
of disease processes in the wide variety of established animal models. While magnetic 
susceptibility becomes an even more significant factor at higher field strengths, this 
enhancement is not always advantageous when localizing and quantifying groups of iron 
oxides that may introduce significant inhomogeneities in the magnetic field. 
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 Figure 2.8 shows that the adiabatic pulse prepared spin-echo acquisition achieves 
good image signal quality without geometric distortions, even at high iron concentrations. 
Similar to the images at 3 Tesla, the ultra-high magnetic field images exhibit the expected 
inverse relationship between the T2-weighted image intensity and adiabatic contrast with 





Figure 2.8: Iron-oxide (mM) nanoparticles in solution (left), T2-weighted spin echo (center) and AFP 




 Quantifying the image contrast at 9.4 Tesla shows a similar linear relationship as 
well. Figure 2.9 shows that the adiabatic contrast is linearly increasing with increasing 
iron concentration. Similarly in this case, iron oxide nanoparticle concentrations were 
used up to the point where very little signal could be detected with the minimum echo 
time for the sequence. Even for these extremes, the contrast remained linearly correlated 










2.4.4 Adiabatic Pulse Preparation Using an Adiabatic Zero Passage 
 
A second approach based on the same contrast mechanism is to use an adiabatic 
zero passage preparation pulse, or two adiabatic full passages applied back-to-back. If the 
duration of the adiabatic full passage is kept constant, then the maximum B1 power 
required to fulfill the adiabatic condition for the zero passage is identical to the full 
passage. Therefore by applying two passages the magnetization is returned to the original 
+z orientation, and total diffusion time for the spins is doubled. This doubling should 
increase the probability of the spins failing the adiabatic condition. This concept will also 
be used in the following chapter with method to compensate for magnetization transfer. 
Figure 2.10 shows that while the adiabatic zero passage contrast increases with increasing 
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 However, the adiabatic zero passage contrast does appear to be linearly correlated 
with iron concentration at the lowest nanoparticle concentrations. Figure 2.11 shows that 
within the iron concentration range from 0.0 to 0.1 mM the contrast is highly linear (R
2
 = 
0.9915). Using the previously defined sensitivity measure, the minimum detectable 
concentration was found to be decreased to 0.02 mM. While high sensitivity and linearity 
over the entire range of iron concentration would be ideal, quantification over a very 
broad range of nanoparticle concentrations may be less likely. In fact with the technique 
using a normalized difference image for contrast measurement, an asymptote will be 
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zero passage preparation at 3 Tesla, this is a function of the pulse parameters and can be 









 Plotting these data together illustrates their complementary potential. While the 
adiabatic full passage contrast remains linear for the entire range of iron concentrations 
studied, the adiabatic zero passage contrast is linearly correlated for very low 
concentrations of nanoparticles and is more sensitive than the full passage contrast. Since 
the expected iron concentration may be estimated in many applications, the two 
preparation techniques offer different approaches, based on the same underlying physics, 
to increase the sensitivity for detecting extremely low nanoparticle concentrations, or to 
increase the linear dynamic range of the contrast for quantifying total iron concentration. 
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affect the contrast. It will also be shown that pulse parameters for either method, such as 









2.4.5 Characterizing Adiabatic Contrast with Different Iron Oxide Core Sizes 
 
Since the contrast is theoretically a function of both the pulse and nanoparticle 
parameters, different sized iron oxide cores were used to characterize the dependence of 
the contrast on iron oxide core size. Since the magnetic field gradients surrounding the 
particle are dependent on both the size of the particle and the magnetic susceptibility 
(59), the relationship between the contrast and total iron concentration is not straight 
forward. For a single total iron concentration, different sized nanoparticles produce 
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nanoparticle during its diffusion also changes. Additionally, increased susceptibility 
effects increase the volume of the strong magnetic field gradients surrounding the 
particle, which also change the probability of a spin diffusing through a sufficient 









 Overall, the adiabatic full passage contrast was linearly correlated with the total 
iron concentration for each iron oxide core size at 3 Tesla. Since the relaxivities of the 
new particles were much greater than the Feridex nanoparticles used in the previous 
experiments, insufficient signal was obtained from the spin-echo images of the higher 
iron concentrations. However, the there was a very high level of linear correlation below 
0.1 mM for each iron oxide core diameter: 15 nm R² = 0.9979, 11 nm R² = 0.9941, 6.9 























Iron Concentration (mM) 
6.9 nm 11 nm 15 nm 
 48 
oxide cores yielded greater changes in adiabatic full passage constant per iron 
concentration. This increase in sensitivity for larger particles did not affect the linear 
correlation of the contrast over the range of iron concentrations up to the point where the 









 These experiments were reproduced at 9.4 Tesla, and there was a similar loss of 
signal at high iron concentrations due to high relaxivity. However, the linear correlation 
of the adiabatic contrast with total iron concentration was preserved. The correlation 
coefficients for the linear fit of contrast and iron concentration for the different core sizes 
were 15 nm R² = 0.9981, 11 nm R² = 0.9889, 6.9 nm R² = 0.9989. It is notable that the 
standard deviations of the measurements were greater at 9.4 Tesla than at 3 Tesla; 
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concentration statistically indistinguishable from zero. Otherwise, the relationship 
between the iron oxide core size and the adiabatic contrast was consistent between the 
experiments performed at 3 and 9.4 Tesla. 
 
 
2.4.6 Characterizing the Effect of Varying Adiabatic Pulse Duration and 
Frequency Sweep on Adiabatic Contrast 
 
 As the results from the full and zero passage experiments demonstrated, the 
adiabatic contrast can be modulated by modifying the preparation pulse parameters, while 
the same mechanism is exploited. While the preceding data used a 10 msec preparation 
pulse because it provided sufficient diffusion distance relative to the nanoparticle spacing 
and was compatible with the total power applied to the sample, the same theory applies to 
pulses of different durations. However, the contrast produced is not expected to be 
identical for different preparation pulse durations. Figure 2.15 shows that different 
preparation pulse durations yield different linear concentration curves, especially for 
higher iron concentrations. The shortest pulse duration is the least sensitive, followed by 
the intermediate length, and the longest pulse duration is the most sensitive to the total 
iron concentration. This relationship is expected from theory, since the increased 
preparation pulse duration is directly related to the increased average diffusion distance 
of the spins. As the average diffusion distance of a spin increases, the probability of the 











 A second pulse parameter that can be modulated is the frequency sweep covered 
by the adiabatic pulse. As was previously shown, this frequency sweep is related to the 
acceleration of the effective field during the preparation pulse and the fulfillment of the 
adiabatic condition. If we use a very high B1 power (approximately 15 dB greater than 
the minimum power necessary to accomplish the adiabatic passage) to ensure that the 
adiabatic condition is fulfilled for all sample preparations, we see that a wider frequency 
sweep is able to successfully invert a greater proportion of the spins (Figure 2.16). As the 
frequency sweep narrows, the adiabatic contrast sensitivity increases. Here, more spins 
fail the adiabatic condition as they diffuse through the magnetic field gradients during the 
narrower bandwidth preparation pulse. The narrow frequency sweep is unable to invert 
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nanoparticles. Optimization using these frequency parameters may be especially 
important for applications where non-nanoparticle sources of off-resonance may be 













2.5 Discussion and Conclusion 
 
 This chapter introduced a method for detecting and quantifying iron oxide 
nanoparticles based on a new contrast mechanism. Monte Carlo simulation and 
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the adiabatic condition in the regions surrounding the nanoparticles. This approach 
produces a contrast that can be visualized as an adiabatic contrast image, and 
nanoparticles in concentration ranges appropriate for molecular imaging show a highly 
linear correlation of adiabatic full passage pulse prepared contrast with total iron 
concentration.  
 
 In addition to using an adiabatic full passage preparation pulse, several 
approaches were developed to modulate the contrast based on the sequence parameters. 
The adiabatic zero passage contrast may be especially useful, since doubling the diffusion 
time increases the probability of a spin encountering a nanoparticle. Also, the full rotation 
of the zero passage preparation returns the magnetization to its original orientation. The 
advantage of this property is highlighted by the nanoparticle quantification at 3 Tesla, 
where T1 relaxation after the application of the full passage pulse may result in a 
measured contrast for pure water different from the expected zero measurement. In this 
case, quantification of pure water with the zero passage produces a near zero contrast. 
This is similar to the result for the full passage at 9.4 Tesla, where the T1 relaxation rate 
of pure water is much longer, and thus there is very little relaxation in pure water for both 
the full and zero passage preparations. It will also be shown in the following chapter that 
the duration and power of the zero passage preparation pulse can be used in a technique 
to compensate for magnetization transfer effects. 
 
 Controlling the size of the iron oxide core presents an opportunity to change the 
size and strength of the magnetic field gradients surrounding the nanoparticles. By 
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comparing different core sizes with the same total iron concentration in the sample, both 
the size of the gradients and the average distance between the particles are affected. This 
is important because for molecular imaging applications there may be very low 
concentrations of contrast agents, and it is ideal to maintain contrast quantification as the 
susceptibility and size of the agents are increased. The results presented show that it is 
not until the signal detection limit of the image acquisition is reached that the 
quantification is compromised. As the contrast is more sensitive to the larger particles at 
a given total iron concentration, this may be an important parameter in choosing an agent 
for an experiment. However, the core size dependence of the contrast quantification 
means that the core size of the particles must be known to interpret the contrast 
measurement. This would not be a concern if a single core size is used, or if a range of 
well distributed sizes can be averaged on a voxel level, but if a range of sizes is 
administered with a narrow size band of particles preferentially accumulating in a tissue, 
the quantification could be compromised. The simplest solution would be to use particles 
of uniform size, though further studies are required to fully to characterize the core size 
dependence. 
 
In the future, it would also be interesting to investigate the effect of the particle 
coating on the adiabatic contrast. This effect may be as significant as the iron oxide core 
size, since restricting spin diffusion near the particle could have the effects of both 
limiting spin access to the strong gradients surrounding the particles as well as slowing 
spins within these gradients. These effects may either restrict or enhance access to the 
strong magnetic field gradients that cause the adiabatic condition to fail, since the net 
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effect is determined by the physical interaction of the iron oxide core coating with the 
diffusing spins. 
 
 Perhaps of greater utility for an image contrast mechanism is the ability to tune 
the contrast sensitivity based on the prescribed sequence parameters. While many 
applications will be limited by the iron oxide nanoparticles available to the researchers, 
pulse and sequence parameters that can be modified during image acquisition present an 
opportunity to optimize contrast detection and quantification. In this chapter, both the 
duration and frequency sweep of the preparation pulse are shown to modulate the 
quantitative adiabatic contrast in agreement with the proposed theoretical mechanism. 
This is useful as the optimal pulse duration will be specific to the application and the 
contrast agent used. For quantification, staying within the linear range may be of primary 
importance, but as it has been shown, this range depends on the specific properties of the 
particles. On the other hand, the modulation of the frequency sweep may be especially 
important when other off-resonance effects are present. By defining the frequency sweep 
to be sensitive to the nanoparticles while avoiding these other components, optimal 
quantification can be achieved. 
 
 Overall, the adiabatic pulse prepared technique yields a contrast that is linearly 
correlated with iron concentration. By modifying both the nanoparticles and the pulse 
sequence, the sensitivity of the contrast can be optimized while maintaining the desired 
linear correlation of the nanoparticles with the contrast. The utility of this approach is 
also greatly aided by the fact that the contrast is achieved during the short duration of the 
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preparation pulse. As will be shown in the following chapters, this allows for a number of 
accelerated imaging techniques to be implemented that generate a reproducible contrast 




CHARACTERIZING ADIABATIC PULSE PREPARED CONTRAST 




 In the previous chapter, a mechanism for producing MR contrast from iron oxide 
nanoparticles that is linearly correlated with iron concentration was described. While the 
results using nanoparticles in solution are very encouraging, translating this work to in 
vitro and in vivo applications requires more realistic phantoms that reflect the challenges 
inherent in quantifying iron concentrations in varied molecular environments. The first 
part of this chapter describes using nanoparticles embedded in agarose phantoms to 
incorporate magnetization transfer and diffusion affects similar to the cellular 
environment. Here, the effect on the contrast is not only characterized, but a method for 
compensating for this effect is proposed and validated based on the molecular mechanism 
of the contrast. Second, the contrast quantification is further characterized by varying 
sequence and environmental parameters, and the approach is compared to other MR 
methods for imaging iron oxide nanoparticles. Finally, the method is applied to two 
complementary models of in vitro molecular imaging. The results show that the adiabatic 
pulse prepared method is not very sensitive to inhomogeneities in the magnetic fields or 
changes in the molecular environment that are not associated with the nanoparticles. 
While the nanoparticles in the cellular imaging studies are no longer uniformly 
distributed as they were in the solution phantoms, the in vitro results are also promising, 
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since the identification and quantification of the nanoparticles remains successful as 
confirmed with molecular iron quantification. Overall, with the development of the 
magnetization transfer compensated approach, a method that is already less sensitive to 
non-nanoparticle effects is able to quantify intracellular nanoparticle concentration in 







 While quantifying iron oxide nanoparticles in solution with MR may be of limited 
utility, there is an ever expanding list of applications of nanoparticles for molecular and 
cellular imaging. Here, the inherent advantages of MRI as a clinically applied, non-
invasive method for imaging with relatively high spatial and temporal resolution make it 
a natural fit for translational studies. However, as has been described, the sensitivity of 
MR is much lower compared to PET (97), even though the simultaneous acquisition of 
high resolution anatomical images with MRI provides complementary information and 
many diagnostic advantages. Applications including tracking SPIO labeled neural cells 
for the treatment of stroke (98) and cardiac stem cells for the treatment of myocardial 
infarction (99) combine the anatomical and functional information provided by traditional 
MR imaging with the ability to use cellular imaging to localize the therapeutic cells and 
evaluate treatment outcomes. With these exciting applications in mind, we aimed to 
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translate the adiabatic pulse prepared mechanism into cellular imaging applications with 
the goal of maintaining a quantitative molecular imaging method. 
 
 Cellular MR imaging encompasses a variety of methods from tracking SPIO 
labeled cells (100), to quantifying an increase in the expression of a cell surface receptor 
(101), and to detecting the upregulation of a gene (17). Additionally, nanoparticles can 
provide important information about the structure and function of tissues by passively 
accumulating in regions where there is a breakdown in vessel permeability (102). Perhaps 
the most straightforward cellular MR imaging application is to label cells with SPIO ex 
vivo and then either implant the cells near the therapeutic target, or administer them 
intravenously and allow them to circulate and passively or actively accumulate in the 
tissue of interest. While cells such as macrophages efficiently take-up the iron oxide 
nanoparticles when incubated with them (103), for many cell types of pathological 
interests such as cancer and stem cells more advanced techniques such as antibody 
conjugation (104) or cell membrane disruption (105, 106) may be required for sufficient 
cellular labeling. 
 
 Since the effect of the nanoparticle on the MR signal is a function of factors 
including the size, composition and coating of the particle, there are many parameters 
that can be modified within a cellular imaging application. In fact, much recent research 
has focused on developing paramagnetic and superparamagnetic nanoparticles that have 
an even greater effect on relaxivity, are more biocompatible, and can be more easily 
modified by surface chemistry for molecular imaging (107). However as these 
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modifications are made to increase the imaging effects, the contrast agent must maintain 
a minimal effect the normal molecular processes and differentiation of the cell. While 
most molecular imaging studies have shown minimal cytotoxicity (108), alterations to 
gene expression remain a significant concern, especially in stem cell studies and at higher 
iron concentrations (109). Some studies have shown changes in cellular differentiation 
(110) and function (111) attributed the interaction of the iron oxide nanoparticles and the 
transfection agents with the normal cellular processes. An additional challenge that is an 
active area of research is the correlation of cell fate with the fate of the image contrast 
(112). While these remain important issues for the development of molecular MR 
imaging, exciting applications have already been developed allowing SPIO labeled cells 
to ask and answer new questions regarding normal physiological development, 
pathological growth and treatment response. 
 
 While these in vitro techniques can efficiently label many cell types, the end use 
of these cells will be within a diverse molecular environment with many physiological 
and magnetic properties. One concern is that the adiabatic preparation pulse may saturate 
off resonance spins that are not associated with the nanoparticles and confound 
nanoparticle quantification through magnetization transfer effects (113). Other areas of 
interest include the sensitivity of the technique to changes in the static and applied 
magnetic fields, as well as the magnetic parameters of the tissue. Since the B0 and B1 
magnetic fields are not exactly uniform, a quantification that is spatially dependent with 
the spatially varying magnetic fields is not ideal. 
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 In this chapter the adiabatic pulse prepared technique is characterized in more 
realistic phantoms and cellular imaging models. Also, a method of compensating for the 
small magnetization transfer effects associated with the preparation pulse is developed 
based on the contrast mechanism. Next, the proposed technique is compared to 
previously proposed methods of iron oxide imaging both for their ability to quantify the 
nanoparticles as well as their sensitivity to environmental parameters. Finally, the in vitro 
cellular imaging potential of the technique is evaluated using two models: first by directly 
labeling cancer cells with SPIO nanoparticles and correlating the image contrast with the 
iron concentration as determined by ex vivo molecular measurement, and second by 
distinguishing cells cultured with iron with and without a reporter gene that promotes 





 The main objectives of this chapter are to (a) quantify magnetization transfer 
effects and develop a method to compensate for them, (b) characterize the dependence of 
the adiabatic contrast on parameters of the imaging system and the molecular 
environment, (c) compare the proposed technique to other methods of quantifying iron 
oxide nanoparticles, and (d) correlate the adiabatic contrast with the measured iron 




3.2.1 Iron Oxide Nanoparticle Phantoms 
 
 Dilutions of iron oxide nanoparticles in solution were prepared as in the previous 
chapter. For phantoms in agarose gel, dilutions of Feridex (Advanced Magnetic, Inc., 
Cambridge, MA) were prepared in water with 2% agarose (Sigma-Aldrich, St. Louis, 
MO) by weight. Nanoparticles were added to the hot agarose solution when it was in its 
liquid state and vortexed to combine. The well mixed samples were then allowed to set at 
room temperature. By visual inspection, the particles appeared well distributed, and the 
agarose was uniform after the phantoms solidified. 
 
 The diffusion dependence of the contrast was investigated by doping the 
phantoms with polyetheleglycol to reduce the diffusion rate. Polyethyleneglycol-400 
(Sigma-Aldrich, St. Louis, MO) was added in specific ratios by weight as previously 
reported (114) to change the diffusion rate of the phantom. Five iron concentrations (0.0, 
0.067, 0.133, 0.5, 1.0 mM) were prepared with five different diffusion rates (2.50e-09, 





3.2.2 Imaging at 3 Tesla 
 
 Adiabatic pulse prepared imaging was performed at 3 Tesla on a Siemens 
Magnetom Trio (Siemens Medical Solutions, Malvern, PA, USA) with a spin-echo 
sequence modified to include either a full or zero passage preparation pulse. A 10 
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millisecond hyperbolic secant pulse with a frequency sweep of -/+ 1000 Hz was used for 
adiabatic full passage, and a zero passage pulse was formed by combining two adiabatic 
full passage pulses back-to-back. Sequence parameters for the cell imaging experiments 
at 3 Tesla included: TE: 15 ms, TR: 10 sec, matrix: 128 x 128, slice: 2 mm, FOV: 100 x 
100 mm.  
 
 For the off resonance saturation (ORS) technique, a Fast Low Angle Shot 
(FLASH) sequence was prepared with a 6 millisecond Gaussian saturation pulse. A 
frequency offset of 1000 Hz was found to provide good quantification for the particles 
used (91), and the power of the saturation pulse was determined experimentally. For the 
frequency selective inversion pulse, a 2 millisecond sinc pulse with a 180 degree flip 
angle was applied as a preparation pulse. Contrast calculation was performed in 




3.2.3 Imaging at 9.4 Tesla 
 
 An adiabatic pulse prepared sequence was also implemented on a 9.4 Tesla 
Bruker BioSpec 94/20 (Bruker BioSpin Corporation, Billerica, MA). The vendor-
provided, optimized hyperbolic secant pulse with frequency sweep -/+ 1760 Hz was used 
for full passage, and back-to-back full passage pulses were used to achieve a zero passage 
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preparation. Other sequence parameters for ultra-high field imaging at 9.4 Tesla were TE: 
10.205 msec, TR: 10 sec, matrix: 128 x 128, slice: 1.00 mm, FOV: 30 x 30 mm.  
 
 The performance of the adiabatic full passage pulse was evaluated by applying a 
single pulse and acquiring the free induction decay (FID). The power of the preparation 
pulse was increased until a full inversion was achieved, and as the power was increased 
past this point there was no change in the signal. This experiment confirmed the 
adiabaticity of the pulse, as well as providing the range of B1 power sufficient for 
adiabatic passage used in the following experiments. To characterize the effects of 
offsetting the pulse frequency from resonance, an irradiation offset was applied to shift 
the frequency of the applied pulse from on-resonance. A range of frequency offsets were 
selected within the frequency sweep, near the bandwidth limit, and beyond the frequency 
sweep to characterize the effect of frequency offset on contrast quantification. 
 
 
3.2.4 Cell Sample Preparation 
 
 Human glioma U87 cells overexpressing the v3 integrin were cultured in 
serum-free RPMI media, and SPIO nanoparticles with a core diameter of 10 nm that were 
conjugated to a small peptide RGD were prepared by Dr. Hui Mao’s laboratory. The cells 
were then incubated with a 0.1 mM concentration of the iron oxide particles for two 
hours at room temperature. Next, the cells were washed with PBS, collected, and re-
suspended in 1 mL of 2% agarose gel. To achieve different nanoparticle concentrations in 
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different samples, different numbers of cells were embedded in the same volume to 
establish a range of total iron concentrations. 
 
 For the endogenous contrast model, a gene with a suspected role in the 
crystallization of iron by magnetotactic bacteria was transfected into a mammalian cell 
line. The AMB-1 mms6 gene was cloned into the pBudCE4.1 vector (Invitrogen, Inc, 
Carlsbad, CA) and transfected into 293T cells. Reporter protein expression, increased 
iron accumulation and increased transverse relaxivity were confirmed in other work. 
Control 293T cells and 293T cells transfected with the reporter gene were incubated with 
200 M ferric citrate for three days. The cells were then washed and re-suspended in 1 
mL PBS. Cells were allowed to settle by gravity for 2 hours at 5 degrees Celsius. Imaging 





3.3.1 Characterizing the Effect of Magnetization Transfer on Contrast 
 
 One challenge that is especially noteworthy for imaging techniques that detect off 
resonance components by saturation is that magnetization transfer (MT) effects that are 
not a function of the nanoparticles can obscure the desired contrast (115). Magnetization 
transfer describes the transfer of magnetization from of spins in a restricted state, often 
associated with macromolecules in vivo, to the mobile pools of spins that are imaged, and 
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the MT effects are detected indirectly (113). While these effects can produce a desirable 
contrast, when this transfer of magnetization is unintended it can confound the contrast 
interpretation. Therefore it is essential to quantify any MT effects that do not originate 
from the nanoparticle dependent mechanism and develop methods for compensating for 
the contrast to increase the accuracy and specificity for the iron oxide nanoparticle 
quantification. 
 
 To test the sensitivity of the adiabatic pulse prepared method to MT effects, 
nanoparticle concentrations identical to the previously described solution phantoms were 
embedded in 2% agarose gel. Replicating the sequence parameters and maximum B1 
power, Figure 3.1 shows that the spin-echo and adiabatic contrast images for the agarose 
phantoms appear similar to previously presented solution phantoms. In both, there is a 
decrease in T2-weighted image intensity with increasing nanoparticle concentration and 
an increase in adiabatic contrast with increasing particle concentration. Importantly, any 







Figure 3.1: Iron-oxide in 2% agarose gel (left) with T2-weighted spin-echo (center) and adiabatic 





 However, after quantifying the contrast, a contrast component appears in the 
agarose gel phantoms that is not present in solution data. Figure 3.2 shows that the 
contrast curve for the agarose appears vertically shifted compared to the contrast 
relationship in solution. However, when only considering the nanoparticles embedded in 
agarose, the adiabatic full passage contrast remains highly linearly correlated with iron 
concentration (R
2
 = 0.9979). In this case, an absolute zero crossing for the contrast at a 
zero iron concentration is not only optimal for iron quantification, but it is necessary to 
develop a contrast mechanism that is specific to the iron content. While relative iron 
quantification within a homogeneous molecular environment may be compatible with the 
shifted contrast versus concentration relationship, a uniform MT effect cannot be 
assumed within an inhomogeneous sample. Since varied molecular environments produce 
spatially dependent MT effects throughout the sample, it is likely not possible to 










 These phantoms where then imaged at 9.4 Tesla to investigate if the same effects 
would be present. Figure 3.3 shows similar results to those described at 3 Tesla, with the 
increase in adiabatic contrast visually apparent in the agarose phantoms. Additionally, the 
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Figure 3.3: Different iron-oxide concentrations (mM) in 2% agarose gel (left) with corresponding T2-




 In fact, quantifying the adiabatic full passage contrast and comparing the results 
to those from the nanoparticle solution phantoms also gives similar results to the 
experiments at 3 Tesla. Figure 3.4 shows the while the adiabatic contrast remains linearly 
correlated with iron concentration, there is an additional contrast component that adds a 
uniform level of contrast to each iron concentration. At 9.4 Tesla, the high degree of 
linear correlation (Feridex in water R
2
 = 0.9955 and Feridex in 2% agarose gel = R
2
 = 
0.9961) and uniform concentration curve shifting is especially notable, since the zero iron 
concentration condition produces virtually zero contrast. The fact that the additional 
concentration components appear so uniform at both field strengths suggests that there 












3.3.2 Compensating for Magnetization Transfer Effects with a Zero Passage 
Adiabatic Pulse 
 
 While the additional contrast component present for the iron oxide nanoparticles 
embedded in 2% agarose gel does not destroy the contrast, it does affect the specificity of 
the contrast and the quantification of the nanoparticles. Developing an iron oxide specific 
measurement method is especially important for in vivo applications, where 
inhomogeneous molecular environments will not provide uniform contrast components 
similar to the phantom experiments. In these cases, the measurements will be confounded 
by the interaction of the inhomogeneous spatial distributions of the MT effects combined 
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in mind, the objective of this work was to develop a method to compensate for the 
magnetization transfer effects on the adiabatic contrast. 
 
 A first idea was to decrease the delivered off resonance RF power by simply 
decreasing the maximum power of the adiabatic pulse. While a pulse with greater power 
than minimally necessary to satisfy the adiabatic condition was used to ensure that the 
adiabatic condition was met for the entire imaging region, this peak power can be 
decreased to characterize the effect of RF power on the adiabatic contrast. It was not 
expected that this method would eliminate the additional contrast component, but given 
our hypothesis regarding the origin of the additional contrast component, the decreased 







































 Figure 3.5 shows that as the power decreases the contrast at the lowest iron 
concentration decreases monotonically as a function of peak RF power. This method is 
able to reduce the additional contrast component by nearly half. However, this approach 
has practical drawbacks that make it not ideal for normal experimental conditions. If the 
peak power is reduced to a point where the failure of the adiabatic condition is no longer 
solely a function of the iron concentration but is also dependent on the spatial distribution 
of the applied B1 field, then any temporary gain in the specificity of the contrast for the 
nanoparticles due to decreasing the RF power and reducing the MT effects would be 
quickly lost if there was insufficient power for adiabatic passage over the entire region of 
interest. Again, while it was not expected that this approach would completely account 
for the MT effects, the characterization of this mechanism led us to develop the following 
more complete approach. 
 
 The objective in developing an MT compensated imaging approach was to 
decouple the desirable diffusion effects that produce the adiabatic contrast from the 
undesirable effects of off resonance power deposited in the sample. Here, the adiabatic 
zero passage introduced in the previous chapter was used, as it doubles the power with 
back-to-back adiabatic full passage pulses without doubling the average spin diffusion 
distance. Since the average diffusion distance increases by the square root of time, 
doubling the duration of the pulse does not lead to a doubling of the average diffusion 
distance. Figure 3.6 shows a schematic of the proposed method in which both adiabatic 
full and zero passage pulse prepared imaging sequences are applied. The full passage 
contrast is then doubled to equalize the power effects on the contrast to the zero passage 
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case; however, this doubling also doubles the diffusion effects. Since the diffusion effects 
of the zero passage adiabatic pulse are less than the doubling of the full passage, 
subtracting double the full passage from the zero passage should yield a contrast that is 
sensitive only to the diffusion effects. By keeping the duration and peak power of the two 









 First, the full and zero passage pulse prepared adiabatic contrasts were quantified 
for iron oxide nanoparticles in 2% agarose gel. Figure 3.7 highlights two important 
findings. First, at the zero iron concentration the zero passage contrast is approximately 
double the full passage contrast, and second, especially for the highest concentration of 
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nanoparticles, the zero passage prepared contrast reaches an asymptote as previous 
described. The doubling of the zero passage iron contrast is especially encouraging, as 
this is what is predicted by theory. The linearity is also interesting as it may be a result of 
either the saturation of the contrast, or it is possible that the magnetization transfer effects 
between the samples are not uniform. In fact, subtle differences in agarose cooling can 
lead to local changes in the agarose composition and deviation from the assumed 
uniformity. By simply shifting the curve to a zero intercept and reducing the contrast by a 
relative amount, the zero passage contrast dependence is artificially modified; however, 
even this method does not address the linearity of the contrast dependence since it does 
not account for the individual variability of the samples. By developing a technique that 
compensates for the MT effects by being both sensitive to the nanoparticles and the 
inherent MT of the sample, a method can be developed that will be effective in conditions 
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 When the previously proposed method of doubling the full passage contrast and 
subtracting the zero passage contrast is applied, the result is a contrast curve with a zero 
crossing and increased linearity. Figure 3.7 shows that even though the MT compensated 
measurement did not require any a priori sample information, the additional contrast 
component is nearly completely removed and the contrast is nulled for a zero iron 
concentration. In fact, compared to Figure 3.6 where an additional contrast component is 
assumed and the curve is shifted, the contrast measure from the proposed MT 
compensated approach appears more linearly correlated with iron concentration than 
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 Compared to the linear correlation coefficients of the full (R
2
 = 0.9842) and zero 
(R
2
 = 0.9662) passage pulse prepared techniques, the linear correlation of the MT 
compensated contrast is indeed increased (R
2
 = 0.9994). However, Figure 3.9 shows that 
this high degree of linear correlation does include slightly negative contrast slightly at the 
zero iron concentration. This measurement may be a result of the decreased saturation 
effect of the second adiabatic pulse. But overall, these pulses achieve their desired effects 
and present a potential mechanism to increase the specificity of the contrast measurement 
to the presence of iron oxide nanoparticles while simultaneously acquiring contrast 
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3.3.3 Characterizing the Effect of B1 and Field Inhomogeneity 
 
 The sensitivity of nanoparticle quantification to the parameters of the imaging 
system is also important, affecting the accuracy of the measurement within an image 
acquisition as well as the reproducibility of the results between acquisitions. Though 
adiabatic pulses are often used with surface coils for RF transmission because of their 
relative robustness and uniformity, if the adiabatic preparation pulse approach is very 
sensitive to inhomogeneities in the static or applied fields, it would be a significant 
concern for translating a quantitative method. In this section, the sensitivity of the 
adiabatic contrast measurement to the peak power and frequency offset of the preparation 
pulse is characterized. 
 
 According to theory, once the adiabatic condition is fulfilled and adiabatic full 
passage is achieved, further increases to the maximum B1 power will not affect the final 
flip angle. Therefore, for the case of nanoparticles in solution, increasing the peak pulse 
power past the level at which the adiabatic condition has been met should not greatly 
affect the contrast. Figure 3.10 confirms this hypothesis as doubling the minimum voltage 
necessary to fulfill the adiabatic condition does not dramatically change the measured 
contrast, even though the peak applied power is now near the voltage limit of the coil. 
However, there are more subtle changes in the quantification, as there does appear to be a 
trend of increasing contrast with increasing power. While the origin of this effect is not 










 Resonance frequency inhomogeneities and offsets over the imaging region of 
interest are a second factor that could confound nanoparticle quantification. For 
techniques where the off resonance is saturated, this can be a major concern, since the 
quantification is directly correlated with the single off resonance frequency. 
Inhomogeneities in the applied and static fields can lead to variable relationships between 
the applied and local resonances, and if these correlations are spatially or temporally 
varying, they can impede nanoparticle quantification either within or between sample 
measurements. Figure 3.11 shows that when the applied pulse is offset by 50, 100 and 
250 Hz the contrast is indistinguishable from the zero frequency offset. Since the 
preparation pulse uses a 1760 Hz frequency sweep, the uniformity of the contrast for 
these offsets is expected. Within the bandwidth of the frequency sweep, the adiabatic 
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through the fluctuating gradients around the particles. However, for frequency offsets 
beyond the bandwidth of the frequency sweep the contrast is substantially reduced. Using 
the frequency sweep, rather than a single saturation frequency, allows the adiabatic pulse 
prepared technique to produce robust nanoparticle quantification in the presence of 









 In order to more fully characterize the relationship between contrast quantification 
and the applied frequency offset, the adiabatic contrast of pure water was measured at 9.4 
Tesla with a smaller, stepwise increasing frequency offset. Figure 3.12 shows the 
expected near zero contrast for both offsets within the frequency sweep and outside the 
frequency sweep, as spins are either fully inverted or returned to their original 
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contrast. When the measured contrast is compared to the simulated Mz magnetization of 
the adiabatic inversion from the Bloch equation shown in Figure 1.5, the adiabatic 
contrast detected from pure water can be explained by the non-zero transition of average 
Mz magnetization between the flat regions inside and outside the frequency sweep. 
Within this region, spins do not perform within the adiabatic regime, and thus the 
apparent adiabatic contrast is a function this transition effect, rather than the presence of 
iron oxide nanoparticles. Importantly, since the range of the frequency sweep can be 





































Frequency offset (Hz) 
 80 
 Changing the diffusion rate of the spins surrounding the nanoparticles may either 
increase or decrease the adiabatic contrast, since the diffusion rate affects the number of 
nanoparticles that are exposed to the strong magnetic field gradients surrounding the 
nanoparticles and the amount of time the spins spend near these gradients. To investigate 
whether the adiabatic approach was sensitive enough to detect changes in the diffusion 
rate, PEG-400 was added to the phantoms to increase the viscosity and decrease the 
diffusion rate. Figure 3.13 shows that while there is little change for the 0.0 mM samples 
without particles added, there is a clear trend of increasing adiabatic contrast with 









 In order to quantify this relationship, the slope of each PEG-400 doped particle 

































in adiabatic contrast as a function of the change in the diffusion rate, or the sensitivity of 
the contrast to the diffusion rate. Figure 3.14 shows that the sensitivity to diffusion rate 
increases with increasing iron concentration, with the highest two nanoparticle 









 These results suggest that the decreased diffusion rates allow more spins, which 
would have otherwise diffused through the magnetic field gradients surrounding the 
particles, to remain long enough so that the local magnetic field gradients can cause the 
adiabatic condition to fail. The increased sensitivity of the higher iron concentrations to 
the diffusion rate may also suggest that there is an additive effect, since the distance 
between the nanoparticles is decreased. Perhaps as the diffusion rate is decreases, the 


















3.3.5 Comparison of Adiabatic Contrast to Existing Methods 
 
 The contrast generated by the adiabatic pulse prepared technique was also 
compared to other methods of quantifying iron oxide nanoparticles such as transverse 
relaxation rate and off resonance saturation (ORS). Transverse relaxation rate (R2 = 1 / 
T1) was measured using a multi-echo, spin-echo sequence with subsequent exponential 
fitting for parameter estimation. Figure 3.15 shows that the there is a linear relationship 
between the adiabatic zero passage contrast and the transverse relaxation rate, especially 
for low iron concentrations. As was previously noted, at higher iron concentrations 
































 Off resonance saturation is another method for generating contrast based on the 
microscopic magnetic field gradients surrounding the particles. In this approach, spins at 
a given off resonance frequency, corresponding to a shell surrounding the nanoparticle, 
are saturated. The number of spins that are saturated is dependent on the volume of the 
shell and the duration of the preparation pulse. Since with ORS the saturation can occur 
on a timescale shorter than the total preparation pulse duration, the effect on the contrast 
can be multiplied as spins continuously diffuse though the saturation shell and are 









 Figure 3.16 shows that while the adiabatic full passage contrast is linearly 
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contrast is much more sensitive at very low iron concentration but becomes insensitive to 
iron concentrations greater than 0.2 mM. While the ORS technique reaches its asymptote 
significantly before an iron concentration of 1.0 mM, a linear contrast region can be 
identified between 0.0 and 0.1 mM. Even though the saturation of the contrast at higher 
iron concentrations is not ideal for iron quantification, the sensitivity of the technique to 










 However, a significant obstacle for the ORS approach is to only saturate the off 
resonance spins that are associated with the iron oxide nanoparticles. Figure 3.17 shows 
that when the nanoparticles are embedded in 2% agarose gel there is a substantial contrast 
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closer inspection reveals that the ORS contrast increases with increasing nanoparticle 
concentration, this change is largely masked by the additional off resonance contrast 
originating from the agarose. As has been described for the adiabatic contrast, even 
though there is a small additional contrast component, the overall relationship between 









 These results were replicated with the nanoparticles of different iron oxide core 
diameters. Figure 3.18 shows that while the relative level of contrast is much greater with 
ORS compared to the adiabatic pulse prepared approach, the quantification still saturates 
within the range of concentrations studied. Notably, the larger iron oxide cores also 
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3.3.6 Comparison to Frequency Selective Inversion 
 
 While the frequency selective properties of adiabatic pulses have been described 
theoretically and with Bloch equation simulations, other pulses have frequency selective 
properties and may be suggested to accomplish similar aims of generating nanoparticle 
contrast. In fact, the IRON method uses this concept to invert and null the on resonance 
signal for subsequent imaging the off resonance component. With this in mind, a 2 
millisecond sinc pulse with a 180 degree flip angle was applied in place of the adiabatic 
full passage. The objective of this study was to test the hypothesis that the mechanism as 
described with the fulfillment of the adiabatic condition could not be replicated by 
applying a conventional, frequency selective 180 degree pulse. Samples with varying 
nanoparticle concentrations and diffusion rates were imaged, and the contrast 
measurement was calculated identically to the adiabatic contrast. While measurable 
contrast was expected from the frequency selected inversion in the presence of the iron 
oxide nanoparticles, the quantitative relationship between the measured contrast and the 










 Figure 3.19 shows that while the contrast generally increases with increasing iron 
concentration, the calculated contrast is neither monotonically increasing within each 
condition, nor linearly correlated with iron concentration for any of the conditions. These 
two factors highlight the robustness of the adiabatic contrast measurement to 
inhomogeneities and the linearity of contrast correlation, which are consequences of the 
adiabatic preparation pulse. While techniques sensitive to off resonance show increased 
intensity in the presence of the field inhomogeneities introduced by iron oxide 
nanoparticles, only the adiabatic preparation pulse that is able to generate a linear contrast 














































3.3.7 Adiabatic Contrast is Linearly Correlated with Intracellular Iron 
Concentration In Vitro 
 
 In the final section of this chapter, two complementary applications will be used 
to test the potential of the adiabatic pulse prepared method for quantitative cellular 
imaging. First, cells incubated with iron oxide nanoparticles and embedded in agarose gel 
were imaged with the full passage preparation. This cellular model introduces both MT 
effects as well as non-uniformly distributing the nanoparticles within the cell after 
uptake. After imaging, biochemical analysis of the samples was used to quantify the true 
iron concentration. Figure 3.20 show that the adiabatic contrast remains linearly 
correlated with iron concentration (R
2
 = 0.9491) in the cellular imaging experiment. 
While there are some MT effects present, as the iron concentration increased the contrast 





Figure 3.20: Adiabatic contrast correlation with intracellular iron concentration at 3 Tesla 



























 One challenge arising from the cellular iron quantification was that while the iron 
concentration was measured over the entire sample, the adiabatic contrast measurement 
only interrogated a subset of the iron loaded cells in a 1 mm slice though the sample. In 
order to have another point of comparison, the R2 was calculated for the slice 
corresponding to the adiabatic contrast measurement. Figure 3.21 shows that the linearity 
of the correlation is increased (R
2
 = 0.9733), especially for the lower iron concentrations. 
This is likely because for lower iron levels the inhomogeneous distribution of a smaller 
number of cells corresponds to a greater sensitivity to the imaging slice selected. By 
measuring the transverse relaxation rate and adiabatic contrast of the same subset of cells, 
































 For comparison, these cell samples were also imaged with the ORS technique. 
Figure 3.22 shows many similarities with the previous results using iron oxide particles 
embedded in agarose gel. For the cellular imaging application, ORS is again very 
sensitive to low iron concentrations, but the contrast measurement saturates at higher iron 
concentrations. It is also important to note that the absolute measure of the contrast starts 
with a high baseline measurement, and as was previously shown, this additional contrast 
that is due to the cell structure and agarose gel can confound nanoparticle quantification. 
Overall, optimizing the ORS technique may provide significant improvements by 
reducing the baseline level of contrast and increasing the sensitive, linear range, but the 
characteristics of the two techniques appear similar in the cellular imaging experiments as 



























 Finally, the proposed technique was applied to an MR gene reporter that is being 
simultaneously developed. Figure 3.23 shows that there is a significant difference in 
adiabatic contrast for samples incubated with and without supplemented ferric citrate. By 
adding the iron supplement, the cells make nanoparticles that can serve as MR contrast 
agents. While not an extensive characterization, these results provide further evidence 
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 In this chapter the adiabatic pulse prepared mechanism was extended in more 
realistic models of iron quantification. It was shown both that the overall technique is 
relatively insensitive to several challenges to quantification as well as that new 
approaches can be developed, while remaining sensitive to the same underlying contrast 
mechanism. Finally, the ability of the method to quantify iron concentration in vitro 
suggests that it is appropriate for quantitative molecular imaging applications. 
 
 The proposed magnetization transfer compensated approach using adiabatic full 
and zero passage pulses produces a contrast that (a) does not have the additional contrast 
component present in the agarose phantoms, and (b) is more linearly correlated with iron 
concentration. The first point follows from the theory, and the second point is likely a due 
to the fact that the quantification is specific to the measured samples. If a single contrast 
component was assumed to be added to all the agarose samples, any individual variation 
between the samples would not be accounted for by the technique. However, since the 
diffusion and power effects on one sample quantification are independent from the effects 
on a second sample, the proposed method produces more accurate iron quantification 
even when comparing between samples with different molecular environments. 
 
 However, it is important to note that while this approach remains sensitive to the 
diffusion of the spins, the penalty for the decreased sensitivity to MT is a decrease in the 
nanoparticle specific contrast to noise ratio. If we assume an average diffusion distance 
for a preparation pulse, d, then the average diffusion distance for during a preparation 
pulse that is twice the duration is, sqrt(2) ∙ d. Therefore from the theory proposed, the 
magnitude of the MT compensated contrast should be reduced by, 2 – sqrt(2). This yields 
an expected decrease in measured contrast by 58.6%, which is in good agreement with 
the experimental results. While the duration of the pulses can be changed, the main 
objective of the approach is to decouple the power and the diffusion distance, which 
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requires keeping many of these variables constant between the two measurements. Future 
developments may aim to quantify this additional component to create a map that can be 
subtracted from the contrast image, or this map may be of interest for independent MT 
measurement applications. In this approach only the relatively small MT specific contrast 
component is removed, rather than simultaneously sacrificing some of the desired 
diffusion based contrast. 
 
 The overall insensitivities to MT, B1 and frequency offset are important in 
developing a method for quantitative imaging. This insensitivity is a function of both the 
mechanism of the contrast as well as the inherent properties of the adiabatic pulse. Since 
molecular imaging in animal models will likely be performed with transceiver surface 
coils, the uniform flip angle of the method alone is important. Other characteristics of the 
contrast measurement, like the sensitivity to the prescribed frequency sweep, present 
opportunities to define the pulse parameters and to modulate the detected contrast. Both 
the frequency at which the transition occurs and the steepness of the transition can be 
defined by the parameters of the hyperbolic secant pulse and tailored for the specific 
application.  
 
 The comparison of the adiabatic contrast with the ORS technique showed that the 
two approaches may be complementary. While ORS is extremely sensitive to very low 
iron concentrations, the adiabatic technique is linearly correlated over a much larger 
range of iron concentrations used in molecular imaging. This is not surprising when the 
theoretical foundations of the two techniques are compared. While in ORS spins are 
continuously cycled through and saturated in a shell surrounding the nanoparticle, in the 
adiabatic technique each spin’s random walk diffusion during the adiabatic preparation 
pulse determines its state for the imaging sequence. While the adiabatic technique is more 
specific for the nanoparticles, the ORS method is especially intriguing for molecular 
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applications where very low particle concentrations are expected. Incidentally, both 
techniques have been shown to be sensitive to changes to the diffusion rate of the sample. 
 
 Finally, the adiabatic pulse prepared technique is able to quantify the iron 
concentration of cells incubated with iron oxide nanoparticles. These studies add several 
complicating factors including (a) the unequal distribution of nanoparticles within the 
cell including clustering in lysosomes, and (b) restricted diffusion associated with the cell 
and organelle membranes. However, the adiabatic approach is able to quantify the 
relative iron content present in varying numbers of cells as confirmed by molecular 
measurements. Future studies will aim at characterizing how the type of iron oxide 
nanoparticle and the type of cell affects the quantification. 
 
 In conclusion, the proposed adiabatic pulse prepared approach is able to quantify 
iron oxide nanoparticle concentrations appropriate for molecular imaging within realistic 
phantom and cellular models. The flexibility of the proposed mechanism allows for the 
measurement to remain sensitive to the desired diffusion effects while mitigating the 
undesired effects arising from the preparation pulse on the sample. Along with other 
techniques, the adiabatic pulse prepared method can be used as a robust method of 









 While the adiabatic pulse prepared sequence produces a contrast sensitive to iron 
oxide nanoparticles that is both quantitative and robust, translating this approach into in 
vivo systems imaging is not simple. For a technique to be generally applied in research or 
clinical settings, technical limitations, in addition to the challenges of live animal 
imaging, must be addressed. Fortunately, since many of the initial studies were conducted 
on a 3 Tesla clinical MR scanner, some technical limitations such as the clinically 
regulated specific absorption limit (SAR) have always been fulfilled. However, imaging 
phantoms and in vitro samples has allowed for very long image acquisition times to 
maximize the SNR and the contrast quantification.  
 
 The first part of this chapter extends the utility of the adiabatic pulse prepared 
sequence by combining the same adiabatic contrast mechanism with methods of 
acquiring images much faster. This reduction in total scan time is not only necessary for 
clinical translation because of the limited availability of clinical scan time, but subject 
motion and the total number of slices acquired are also hurdles for translation. In addition 
to the initial adiabatic pulse prepared standard spin-echo (SE) sequence, adiabatic pulse 
prepared Turbo Spin-Echo (TSE), Half-Fourier Acquisition Single Shot Turbo Spin Echo 
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(HASTE) and Fast Low Angle SHot (FLASH) sequences are developed. These different 
image acquisition schemes yield consistent contrast quantification but with a dramatic 
reduction in image acquisition time. In the second section, an experiment is designed 
where iron oxide nanoparticles are intravenously administered to mice and allowed to 
accumulate in the liver over a period of 24 hours. Then the mouse liver is imaged, and the 
contrast measured by the adiabatic pulse prepared sequences is correlated with the total 
liver iron measured by biochemical analysis. Together, these studies show that the 
proposed approach can be modified and translated to in vivo imaging based on the 





 Targeted molecular imaging may be the most exciting and ambitious application 
of iron oxide nanoparticles. While in cell tracking the cell of interest is generally known 
and labeled, targeted imaging aims to hone the nanoparticles to cells in the body based on 
their physiological or molecular characteristics. When the contrast agents are combined 
with pharmaceutical therapy (116), these probes can characterize the pathophysiological 
molecular markers while simultaneously delivering therapy. As contrast agents are 
designed to target specific biomarkers of disease and changes in physiology, a natural 
disease of interest is cancer. Here, the expression of different cell surface proteins 
compared to healthy tissue provides disease specific targets for the nanoparticles (117). 
Additionally, by characterizing the molecular and physical characteristics of the tissue, 
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probes can be designed to selectively accumulate in the tissue of interest and provide 
contrast in MR images. 
 
 Targeted contrast agents for in vivo imaging can generally be divided into either 
passively or actively targeting (43). Passive targeting describes the process of contrast 
agents accumulating in tissues based on factors other than their molecular profile. 
Particles may be phagocytosed differently by different cell types, escape through the 
leaky vasculature of a tumor, or accumulate in tissues based on the physical parameters 
of the particles and the vessels. While these changes provide information about the state 
of the cells and the tissues, they are not designed to detect or quantify the expression of 
molecular markers of cancer. Active targeting conjugates a specific molecule to the 
nanoparticle coating that can bind to the target of interest. Once the contrast agent binds 
to the molecule, the complex may be taken up by the cell where the iron oxide 
nanoparticle will continue to decrease the transverse relaxation rate (118). Generating 
detectable contrast is a challenge for this approach. While a level of molecular specificity 
and sensitivity similar to PET remains a goal, new approaches may be required to 
enhance the accumulation of the particles and to amplify the changes in the MR signal. 
 
 Imaging macrophages after intravenous iron oxide nanoparticle injection was one 
of the first clinical applications of passively targeted particles (119). It was observed that 
the particles were phagocytosed by specialized macrophages in the liver known as 
Kupffer cells. These normal cells are absent in cancerous tissue, and therefore regions 
that are not responsive to the contrast agent raise the suspicion of malignancy (120). 
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Feridex IV (Advanced Magnetics, Lexington, MA) was approved by the FDA for aiding 
in the diagnosis of liver masses by MRI (121). Due to their predilection for phagocytosis 
and the ubiquitous roles of the immune system in the human body, studies characterizing 
many other disease processes including autoimmune (122) and atherosclerotic plaque 
formation (123) have been designed using the same principles but with particles selected 
for the specific disease application. 
 
 Changes in vascular physiology and vessel integrity can also be major drivers for 
nanoparticle accumulation. While particles can be designed to circulate for longer periods 
of time, by avoiding being trapped in the capillaries or excreted in the kidney, changes in 
vessel integrity can lead to the escape of the particles out of the circulation. Tumor 
angiogenesis produces leaky vessels where particles extravagate and passively 
accumulate in the tumor tissue (124). While such a crude method may have limited 
applications for clinical cancer screening, a complementary method has been explored for 
screening lymph nodes for metastatic disease based on nanoparticle accumulation (125). 
However in the case of lymph nodes, the MR intensity is less affected by the contrast 
agent in metastatic tissue (126). The advantage of these passive accumulation methods is 
that higher doses of contrast agent can drive the accumulation of more nanoparticles in 
the tissue, without the need for cellular binding and uptake. However, if the goal is to 




 Active targeting uses molecules conjugated to the surface of the nanoparticle to 
increase the binding and localization of the particles. For these approaches, antibodies 
and other proteins can be linked to the surface coating of the iron oxide to increase 
molecular specificity (127). Prominent examples include imaging cancer and 
angiogenesis by targeting the Her-2/neu receptor (128) and VCAM-1 (129). Non-
invasive methods for quantifying receptor expression allow disease progression and 
treatment response to be monitored. As these molecular changes precede the anatomical 
and physiological changes conventionally measured by MRI, molecular imaging methods 
provide new biological insights. However while the number of potential molecular targets 
is as expansive as the diverse molecules expressed in the cell surface, the challenge 
generating sufficient MR contrast based on a relatively small number of molecules 
remains. Additionally, since the particles are often administered intravenously and then 
must be honed to the tissue of interest, localization of the contrast agent alone can be a 
significant obstacle. 
 
 Despite these challenges, MRI remains a promising modality for in vivo 
molecular imaging as a non-invasive and safe method for acquiring high resolution 
images with good soft tissue contrast. Also, the growth of MRI in the clinical setting 
cannot be underestimated for potential clinical translation. With these developing clinical 
and research applications for human and animal imaging in mind, the following work 
aims to develop an adiabatic pulse prepared approach appropriate for in vivo imaging and 
demonstrate it in an animal model. The sensitivity of the proposed method to the 
microscopic magnetic field inhomogeneities surrounding the nanoparticles should present 
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many advantages for contrast specificity to the nanoparticles as has been detailed. 
However, translation into in vivo models is challenging for nearly all imaging techniques, 
since the varied environments and cardiac and respiratory motion can significantly erode 
the quality of the images and the performance of the contrast mechanism. 
 
 In this chapter, the in vivo potential of the adiabatic pulse prepared contrast 
method is investigated first by overcoming a known technical challenge and second by 
testing a passive targeting model with ex vivo validation. Since a standard spin echo 
sequence requiring several minutes to acquire one image is insufficient for live animal 
imaging, adiabatic pulse prepared TSE and HASTE sequences are implemented. These 
imaging techniques maintain the adiabatic contrast by leaving the preparation module 
untouched, but they significantly reduce the total imaging time by acquiring multiple 
lines of k-spaces following a single adiabatic preparation. Finally, iron oxide 
nanoparticles that preferentially accumulate throughout the mouse liver are administered 
intravenous in different doses and allowed to circulate and accumulate before quantitative 
imaging. The livers are then removed and biomolecular methods are used to quantify the 
iron content in the liver, which is then correlated with the image contrast. Together, these 
aims demonstrate the flexibility of the approach and validate the quantification of the 






 The in vivo potential of the proposed technique is investigated by applying the 
adiabatic contrast mechanism to a passive targeting model. To accomplish this objective 
(a) sequences with reduced total imaging times compatible with the in vivo studies but 
without compromising image contrast were implemented and validated, and (b) an in vivo 
passive targeting experiment was used with ex vivo quantitative tissue analysis to 
correlate the imaging results with the iron content. 
 
 
4.2.1 Developing Alternative Imaging Strategies for Adiabatic Pulse Prepared 
Sequences 
 
 In order to decrease the total contrast acquisition time, multiple lines of k-space 
were acquired following a single adiabatic preparation pulse. Similar to the adiabatic 
pulse prepared spin-echo sequence, adiabatic pulse prepared Turbo Spin Echo (TSE) and 
Half-Fourier Acquisition Single-Shot Turbo Spin-Echo (HASTE) sequences were 
developed in the Siemens IDEA environment. For the TSE sequence, multiple refocusing 
pulses are applied following the excitation acquiring multiple lines of k-space within a 
single TR. The number of echoes acquired is defined by the Turbo Factor (TF), with a 
higher TF reducing the total scan time for a given TR. However, an important 
consideration, especially for higher TFs, is that the signal magnitude decreases in time 
with the T2 decay envelope. HASTE is an extreme extension of this approach with all the 
echoes being acquired after a single excitation. The acquisition time is further decreased 
 102 
by using the symmetry of k-space to reduce the total area of k-space acquired. The T2 
weighting of the HASTE approach is therefore even greater than for the TSE sequence. 
 
 All sequences were designed within the Siemens IDEA programming 
environment and implemented on a 3 Tesla Siemens Magnetom Trio (Siemens Medical 
Solutions, Malvern, PA). The preparation pulse parameters were identical to the previous 
spin-echo sequence with a 10 millisecond hyperbolic secant pulse applied prior to the 
imaging scheme. The TR was extended to 10 seconds to allow greater recovery of the 
spin system. Other imaging parameters were identical to the conventional spin-echo 
experiments with the notable exception of the echo time. Since the effective echo time of 
the accelerated imaging sequence is a function of the TF, the total imaging time and the 
effective echo time are correlated. However, since the echo time is the same for the 
prepared and non-prepared images, the calculated adiabatic contrast is only a function of 
the adiabatic preparation pulse and not the effective echo time. Iron concentrations were 
selected from 0 mM to 0.25 mM, a range in which sufficient signal remained for contrast 
calculation even at long effective echo times. 
 
 
4.2.2 Iron Oxide Nanoparticle Administration for Mouse Liver Imaging 
 
 An experiment was designed to test the ability of the method to quantify low 
concentrations of nanoparticles in a living animal model. By experience, different doses 
of intravenously administered particles that predominantly accumulate the mouse liver 
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were used to generate different in vivo liver iron oxide nanoparticle concentrations. The 
nanoparticles used were amphipilic triblock copolymer coated iron oxide nanoparticles 
with a core size of 15 nm and a zeta potential of -30 mV (Ocean NanoTech, Springdale, 
AR). In each sample group, three 4-6 week old female balb/c mice received a single 
intravenous dose of nanoparticles (1, 2.5, 4, or 5 mgiron/kgbody weight). The particles 
circulated and accumulated in the liver tissue for 24 hours before MR measurement. 
 
 Imaging was performed on a 3 Tesla Siemens Magnetom Trio (Siemens Medical 
Solutions, Malvern, PA). The animals were anesthetized with ketamine/xylazine and two 
animals were placed side-by-side inside the transceiver wrist coil. The imaging 
parameters used were similar to the phantom experiments at 3 Tesla: TR: 5 sec, TE: 14 
msec, TF: 4, Field of View: 90 mm x 90 mm, Matrix: 128 x 128. The turbo factor used 
was a compromise between the objectives of decreasing the duration of the image 
acquisition and generating sufficient signal for accurate quantification despite T2 decay. 
Additionally, an ultrashort echo time (UTE) sequence was used for comparison: TR: 8.19 
msec, TE: 0.07 and 5.06, slice thickness: 0.52 mm, Matrix: 192 x 192, slices: 192, phase 
encode directions: 48000, Field of View: 99 x 99. The ultrashort echo time allows the T1 
effects of the iron oxide nanoparticles to be imaged, producing an increased signal. 
 
 Following the imaging experiments, the animals were sacrificed and the liver 
tissue was removed for biochemical analysis. The organ was digested with nitric acid and 
the 1,10-phenanthroline test was used to quantify the total iron content. A calibration 
curve of known iron concentrations was created within the range of liver iron 
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concentrations, and the liver iron was measured by spectrophotomeric comparison. The 
measured value for the animals administered iron oxide nanoparticles was then subtracted 
from the 0.32 mgiron/gtissue baseline liver iron concentration to yield a normalized iron 






4.3.1 Developing Different Adiabatic Pulse Prepared Imaging Techniques to 
Decrease Total Imaging Time 
 
 While the conventional spin-echo technique produces high quality images with 
relatively short echo time, the major disadvantage of this approach for translational work 
is the long image acquisition time. Since the total imaging time is a product of the 
number of k-space lines acquired and the repetition time, allowing for the relaxation of 
the spins before the next preparation requires at least 5 to 10 seconds for imaging at 3 and 
9.4 Tesla. When this time is multiplied by an average matrix size of 128 or 256 lines, the 
total acquisition time for a single image quickly increases to more than 10 minutes. Since 
a second image is required without the preparation pulse, the total contrast imaging time 
may be impractical, especially for clinical translation. Fortunately, the adiabatic contrast 
is only a function of the preparation pulse, approximately 10 milliseconds in the current 
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studies. If the image acquisition period could be accelerated, the adiabatic contrast could 
be measured on the order of seconds rather than minutes. 
 
 Spin-echo based acquisitions were first explored, especially with the image 
quality gained in the presence of the large susceptibilities of the nanoparticles. Adiabatic 
pulse prepared TSE and HASTE sequences were implemented on a 3 Tesla clinical MR 
scanner to acquire multiple lines of k-space after a single preparation and excitation. With 
the TSE sequence, the number of k-space lines acquired after a preparation can be 
defined by the user at scan time. Increasing the number of lines increases the speed of the 
acquisition; however, it also increases the effective echo time of the image. This can be a 
significant tradeoff when imaging iron oxide nanoparticles as they can dramatically 
increase the transverse relaxation rate, and the adiabatic contrast calculation is not 
possible if there is no signal detected at the long effective echo time. 
 
 Adiabatic full passage contrast acquired with the TSE sequence and a turbo factor 
(TF) of 7 shows the familiar linear relationship of adiabatic contrast with iron 
concentration in Figure 4.1. The linear correlation of the contrast remains strong even 
though the total scan time has been decreased by a factor of 7: 15 nm R² = 0.978, 11 nm 
R² = 0.9961, 6.9 nm R² = 0.9914. Also, even though the effective echo time of the 
acquired images has increased and the signal intensity decreased, the calculated contrast 
is reproducible. Since the adiabatic contrast is the normalized difference of images of 
same effective echo time with and without the preparation pulse, the contrast is 










 To push the accelerated image acquisition further, an adiabatic pulse prepared 
HASTE sequence was implemented, using half-Fourier acquisition to acquire the entire 
image after a single preparation and excitation. Overall, Figure 4.2 shows a similar 
contrast relation to the TSE sequence, especially for the 6.9 (R
2
 = 0.9932) and 11 nm (R
2
 
= 0.9977) iron oxide core sizes. However, the highest nanoparticle concentration does not 
maintain the linear relationship for the 15 nm iron oxide core size. For these conditions 
the high transverse relaxation rates and long effective echo times decrease the signal to 
noise ratio of the images, and the contrast asymptote begins to be reached. However, for 
the lower iron concentrations the HASTE sequence quantified the adiabatic contrast from 
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 In order to test the hypothesis that the adiabatic contrast is only a function of the 
adiabatic pulse preparation, and not the image acquisition sequence, the contrast 
measurements of the conventional spin-echo, TSE with increasing TF and HASTE 
sequences were compared. Figure 4.3 shows that while there is nearly a factor of 100 
difference between the longest and shortest image acquisition time, the contrast remains 
largely consistent. This is highlighted by focusing on the changes with increasing TF in 
the TSE and HASTE sequence in Figure 4.4. Here, it is clear that the particle 
quantification is not compromised by decreasing the imaging time. As long as sufficient 
image intensity can be acquired by the imaging sequence, measuring the contrast 
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 Finally, an adiabatic pulse prepared gradient echo sequence was designed for 
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preparation was used to return the magnetization to the +z direction. While there is still 
one excitation of each repetition time, since this the magnetization is returned to the 
original orientation the repetition time can be decreased, unlike with the spin-echo 
method. Figure 4.5 shows that there is indeed a positive correlation of the adiabatic 
contrast with iron concentration that is especially linear for the longer repetition times of 
5 seconds (R
2
 = 0.9979) and 10 seconds (R
2
 = 0.9991). However, the relationship is less 
linear for shorter repetition times such as 500 milliseconds (R
2
 = 0.896) and 1 second (R
2
 
= 0.9509). While spins that do not fail the adiabatic condition are returned to their 
original orientation for the next preparation pulse, spins that fail the adiabatic condition 
require additional time to fully relax. While the contrast with the shorter repetition time is 
still apparent, iron quantification is compromised as the spin distribution is not identical 
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4.3.2 Quantifying Iron Oxide Nanoparticles In Vivo 
 
 In vivo molecular imaging presents many practical challenges including the 
interaction of the dynamic system with the imaging physics. To extend the proposed 
technique into an animal system, the passively targeted accumulation of iron oxide 
nanoparticles was used to emphasize the ability of the approach to quantify low 
concentrations of nanoparticles. Since the liver is a relatively large organ and the iron 
concentration can be measured ex vivo for imaging correlation, these principles were 
applied to correlate the iron concentration with the image contrast.  
 
 Spin echo and adiabatic contrast images were successfully acquired using the TSE 
accelerated imaging approach. Figure 4.6 shows both that the image quality of the animal 
images is sufficient to identify the liver in the spin-echo image and that the adiabatic 
contrast images show increased signal in the liver region. Using identical image scaling, 
it is apparent that the overall image intensity of the adiabatic contrast image (center 
panel) is greater than the MT compensated contrast (right panel). This decrease in 
contrast is especially noticeable in the anterior and posterior muscle, which should not 










 While the visualization of the contrast is encouraging, the true test of the 
technique is to quantify low iron concentrations. In Figure 4.7 there is a clear linear trend 
of increasing adiabatic contrast with increasing iron concentration (R
2
 = 0.7366). Equally 
noteworthy is that there is a near zero crossing of the adiabatic contrast at a zero 
normalized iron concentration. Also, even though the measured system and approach are 
different, the dynamic range of the adiabatic contrast remains consistent with the 










 The MT compensated approach is a second approach to contrast quantification 
that is expected to yield a quantification that is more specific to the iron oxide 
nanoparticles. Figure 4.7 shows the linear correlation of image contrast with the 
measured iron concentration that is similar (R
2
 = 0.7398) to the adiabatic full passage 
contrast. While the MT compensated approach does not appear to have significant 
advantages over the full passage method for quantification, the images in Figure 4.6 show 
the advantage of the MT compensated approach with the increased nanoparticle 
specificity. It is also notable that while extending the correlation to the zero iron 
concentration yields a negative contrast measurement, this is similar to the phantom 
experiments. As in the previous case, this negative contrast measurement is attributed to 
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 In an incidental finding, a region of increased adiabatic contrast was observed in 
one of the animals outside the liver. Using the simultaneously acquired anatomical 
images, the contrast region was identified as the bladder. This finding was not observed 
in any of the other subjects, and it was not expected that the nanoparticles would be 
significantly excreted in the urine within the circulation period. Figure 4.9 shows that 
while the region of increased intensity appears as a well demarcated area in the animal on 
the left, the corresponding region in the animal on the right has a lack of signal consistent 
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 In order to further classify the contrast region, UTE images of the corresponding 
slice were acquired. Figures 4.10 and 4.11 show that while the right arrow highlights the 
dark region expected in the normal bladder fluid with a long longitudinal relaxation time, 
there is a dramatic increase in signal in the bladder of the animal on the left. In fact, using 
the two echo times it is apparent that there may be an accumulation of nanoparticles in 
the bladder that is causing a shortening of the longitudinal relaxation time. This effect 
causes the increased signal intensity on the UTE images. As with the increased adiabatic 
contrast intensity, the increased signal intensity in the UTE images was only found in this 
single subject. While the physiological or anatomical explanation of this result is not 
clear, the results taken together suggests that the iron oxide nanoparticles were filtered 
through the kidney and into the urinary tract where they accumulated in the bladder. 
These findings provide further evidence that the adiabatic pulse prepared approach can 
















4.4 Discussion and Conclusion 
 
 The adiabatic pulse prepared contrast technique can be translated to in vivo 
imaging and can quantify low iron oxide nanoparticle concentrations. In the first part of 
this chapter, with knowledge of the contrast mechanism, the adiabatic approach was 
made compatible with in vivo experiments without affecting the nanoparticle 
quantification. Finally, an experiment was designed to show that in vivo nanoparticle 
concentrations are sufficient for contrast detection and quantification. 
 
 While the theoretical basis of the in vitro experiments of the previous chapter can 
be applied to the in vivo studies, there are practical challenges that stand as significant 
obstacles for translating MR imaging techniques to living systems. The most obvious 
challenge is often that the duration of the imaging sequence must be short enough to be 
compatible with in vivo studies. A primary advantage of the adiabatic approach is that the 
contrast is achieved during the preparation pulse, which is on the order of milliseconds. 
In theory, the image acquisition time can be decreased without affecting nanoparticle 
quantification. Even though the signal to noise ratios of images acquired with a 
conventional spin-echo and a HASTE sequence may be very different due to the different 
pulse sequences and different parameters, since the contrast quantification is a 
normalized difference of similar images the contrast is reproducible Using the TSE and 
HASTE sequences it was shown that the quantification was very reproducible even as the 
imaging time was decreased by a factor of nearly 100. The main concern with the 
accelerated imaging sequences is that sufficient signal is acquired after the preparation 
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pulse, and as is demonstrated by the extreme example of the HASTE sequence, if the 
effective echo time is increased too far the quantification is affected. 
 
 The successful implementation and results of the adiabatic pulse prepared TSE 
sequence lead directly to the in vivo experiments. While the results showed that the 
quantification was insensitive to either the TF of the TSE sequence or even the HASTE 
sequence, for the animal studies the image quality and effective echo time of the 
sequences was a consideration. Experimentally, it was found that a TF of greater than 4 
resulted in a noticeable reduction in anatomical image quality obtained with the current 
parameters, and since this level of acceleration allowed images to be obtained within a 
reasonable anesthesia period it was used for the in vivo data. In the future, other technical 
additions such as parallel imaging may be able to further decrease the imaging time while 
maintaining SNR. It should also be noted that the contrast image quality was not 
noticeable effected by the macroscopic susceptibility effects of the nanoparticles or the 
air/tissue interfaces. 
 
 The adiabatic full passage and MT compensated sequences show a contrast that is 
linearly correlated with the ex vivo liver iron concentration. These data show the expected 
linear trend, but there is a greater deviation from the linear correlation than in the 
phantoms. However, this is not unexpected or necessarily an error in the measurement. 
The factors that effected the in vitro quantification, such as calculating a single contrast 
measurement for an entire organ, smooth the correlation of the contrast measurement and 
the nanoparticle concentration. As in the studies quantifying the whole volume iron 
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concentration based on a single slice, the measured contrast does not necessarily reflect 
the local concentration. The ability of the technique to localize nanoparticles in a more 
realistic model of iron oxide nanoparticle delivery will be explored in the final chapter. 
 
 The zero crossing of the adiabatic full passage contrast with the normalized iron 
concentration is also notable. In this measure the iron concentrations of the individual 
subjects were subtracted from an average mouse liver iron concentration to yield a more 
specific measure of mouse liver iron oxide nanoparticle concentration. This measure may 
be especially useful, since strong microscopic magnetic field gradients are a function of 
the properties of the iron oxide structure. Here, free iron or other iron oxides in the liver 
have a much smaller effect on the local magnetic field compared to the administered iron 
oxide nanoparticles that are composed of magnetite and optimized for their effects on the 
local magnetic field. 
 
 Finally, the incidental finding of the increased adiabatic contrast intensity in the 
bladder of a single subject provides a serendipitous positive control. Taken with the 
increased signal intensity on the UTE images, these data strongly suggest that iron oxide 
nanoparticles entered the urinary system and created a high nanoparticle concentration 
solution in the bladder. The well circumscribed region with high contrast intensity 
resembles the iron oxide solution phantom results. As previously described, it is not 
surprising that the localization and quantification of the nanoparticles in tissue is much 
more challenging compared to phantoms, but these results highlight the potential of using 
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the adiabatic preparation pulse method for imaging nanoparticles in other animal 
applications. 
 
 In conclusion, with the theoretical foundation provided by the previous chapters 
an adiabatic pulse prepared approach suitable of in vivo imaging was implemented on a 
clinical MRI scanner. Since the contrast is only a function of the very short preparation 
pulse period, robust contrast quantification with the acceleration of the imaging sequence 
is a major advantage for research and clinical translation. As the in vivo animal studies 
show, while the physiological motion of the animals presents challenges for image 
quality and contrast quantification, the adiabatic pulse prepared approach yields 
promising results for specifically quantifying iron oxide nanoparticles. This new 
mechanism for generating quantitative MR contrast from nanoparticles may have many 








5.1 Problem Statement 
 
 As the number of applications using iron oxide nanoparticles to explore the 
pathophysiology, diagnosis and treatment of diseases increases, new methods for 
detecting and quantifying the particles are required. While many methods have been 
proposed that are sensitive to macroscopic changes in the magnetic field surrounding the 
nanoparticles, these techniques may also be sensitive to other effects, and therefore the 
contrast is not specific to the nanoparticles. Also for applications such as quantifying 
molecular receptor number in a cancer model, quantification is essential. Ideally, an iron 
oxide nanoparticle contrast should be linearly correlated with iron concentration, 
reproducible, insensitive to fluctuations in the imaging system, and acquired on a time 




 This work presents a technique for the quantitative molecular imaging of iron 
oxide nanoparticles using adiabatic preparation pulses. This new contrast mechanism is 
supported by numerical simulation and experimental results. During the adiabatic 
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preparation pulse, the adiabatic condition is not fulfilled for spins diffusing through the 
rapidly changing microscopic magnetic fields surrounding the nanoparticles. The 
probability of the adiabatic condition failing is directly proportional to the distance 
between the nanoparticles, which is a function of the nanoparticle concentration. In 
Chapter 1, it is shown that the adiabatic contrast is linearly correlated with the total iron 
concentration for several preparations of iron oxide nanoparticles. Additionally, the 
technique can be implemented on clinical and ultra-high field research MR scanners, the 
adiabatic mechanism can be extended to produce a zero passage adiabatic contrast and 
the sequence and pulse parameters and be modified to increase the sensitivity of the 
measured contrast. 
 
 The approach is applied to more realistic molecular environments and cellular 
imaging in Chapter 2. A technique for magnetization transfer compensation is developed, 
the effect of diffusion on the contrast is quantified, and the linearity of the contrast for 
endogenous and exogenous iron oxide contrast agents is presented. Finally, in Chapter 3 
accelerated imaging acquisition schemes to acquire adiabatic pulse prepared images in 
seconds without sacrificing contrast and a passive accumulation model of in vivo 
quantitative iron oxide imaging are demonstrated. This work greatly extends the 
demonstration of the technique for quantifying iron oxide nanoparticles in solution, since 
the molecular environment of the particles and their physical interactions is vastly 
different in vitro and in vivo compared to in well dispersed solutions. This work shows 
that not only is the proposed technique capable of quantitative molecular imaging under 
these conditions, but that modifications to the pulse sequence and the pulse parameters 
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5.3 Future Directions 
 
5.3.1 Receptor Targeted Cancer Imaging Using Iron Oxide Nanoparticles 
 
 While cell surface receptor targeted nanoparticles are an ideal application for 
quantitative, in vivo molecular MR imaging, these studies face many technical challenges 
including the transport of the nanoparticles to the site of interest, low particle 
concentration for imaging, and a continuous distribution of nanoparticles. In order to test 
the ability of the adiabatic technique to identify and quantify iron oxide particles within 
this challenging environment, tumors from animals that had received intravenous 
injection of targeted particles were kindly provided by C. Kessinger and J. Gao at the 
University of Texas Southwestern Medical Center in Dallas, Texas. 
 
 In this model, HT1080 (fibrosarcoma) cells were implanted and formed tumors in 
the dorsal flank of nude mice. Then cRGD encoded, SPIO-loaded micelles targeting the 
v integrin on the tumor cells were injected intravenously through the tail vein and 
allowed to circulate for 1.5 hours. Following particle circulation, the animals were 
sacrificed and the tumors were excised, fixed in formalin and suspended in PBS for 
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imaging. Imaging was performed at 9.4 Tesla as previously described, and the tumor 
orientation was noted for correlation with Prussian Blue histological staining. 
 
 Figure 5.1 shows a region of corresponding decreased signal on T2-weighted 
imaging, increased adiabatic contrast and positive histological staining for iron. Taken 
together, these results suggest that the technique may be sensitive enough to detect 
nanoparticles in molecular MR applications. One notable finding is that the particles did 
not produce a large contrast region extending beyond the region where the nanoparticles 
were located, but rather the contrast resembles a continuous distribution of particles 
within a confined area. It is also important to note that while there is a heterogeneous 
signal from the surrounding tumor and PBS in the spin-echo image, these varied 
components are all nulled in the adiabatic contrast image. A technique that is sensitive to 
the nanoparticles is extremely important as very low concentrations of nanoparticles must 










 However, many challenges exist for these applications including registering the 
MR images with the histological staining and validating the contrast quantification. In 
fact, a direct injection experiment where iron oxide particles are injected into a tumor or 
muscle, or where labeled cells are implanted, may be necessary to validate the local, 
quantitative distribution of nanoparticles. While targeted molecular models are still the 
ultimate goal, for the purposes of developing the technique it was necessary to reduce the 
confounding challenges of nanoparticle delivery and accumulation. In this way, the same 
approaches for optimizing the sensitivity and specificity of the contrast presented in 
Chapter 2 can be applied to in vivo molecular MR imaging. 
 
 
5.3.2 Adiabatic Pulse Prepared Liver Iron Imaging 
 
 Finally, human imaging using the adiabatic pulse prepared technique is not 
limited to iron oxide nanoparticles being developed as contrast agents. Human iron 
imaging is of growing interest as iron accumulations and their deleterious effects are 
being recognized in a number of chronic diseases. MR is an ideal modality for disease 
surveillance as rich soft tissue information can be acquired over an entire organ, 
compared to the spatially limited information provided by invasive biopsy. One organ of 
interest is the liver, where both primary iron diseases, such as haemochromatosis, and 
non-alcoholic fatty liver disease can change the fat and iron composition of the organ and 
increase the probably of developing hepatocellular carcinoma. 
 
 125 
 Liver phantoms with 10% oil and varying iron concentrations were kindly 
provided by Drs. Nashiely Pineda and Diego Martin. Imaging was performed at 3 Tesla 
using the adiabatic pulse prepared HASTE sequence for accelerated imaging. The 
objective of this study was to see if the linear correlation of the adiabatic contrast and 
iron concentration was maintained in a realistic liver phantom. Figure 5.2 confirms that 
the linear correlation is preserved with R
2
 = 0.9928. The liver phantoms presented several 
additional challenges including an increased number of molecular components in the 
phantoms, increased size compared to the previously used 1.5 mL phantoms, and since 
they were imaged simultaneously, a larger overall area for the B0 and B1 fields to cover 
for homogeneous quantification. Taking these facts into account, the technique performed 
well; however, the notable contrast at a 0 mM iron concentration highlights the need for 
developing additional methods to reduce magnetization transfer and increase the 
specificity of the contrast. Here, optimizing the RF pulse may be especially high-yield as 
the presence of off-resonance components in the liver phantoms that were not included in 











 Further studies are needed to correlate human contrast measurements with 
biochemical measurements of iron, such as from longitudinal liver studies of iron content 
with biopsy or liver transplantation studies where organs undergo extensive MR imaging 
and histological analysis. However, it appears that the proposed technique can be 
translated to the clinical setting where adiabatic contrast images can be acquired 
simultaneously with high quality, T2-weighted images at no additional time cost. While 
there are several avenues for further optimization, the adiabatic pulse prepared approach 
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